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African Americans (AA) are more susceptible to end-stage renal disease (ESRD) for several
reasons. Treatment options for patients with ESRD include dialysis therapy and transplantation,
with the latter typically producing better outcomes. AA are less likely to complete the medical
evaluation process, which requires patients to consult with doctors and undergo a series of tests
and examinations. This study sought to determine the factors that predict completion of the
medical evaluation for AA ESRD patients using a mixed methods design. Participants consisted
of transplant professionals (N=23) recruited from nine transplant centers in the Mid-Atlantic,
Mid-Western and Southeastern parts of the United States, and kidney patients (N=30 patients)

recruited from one transplant center in the Mid-Atlantic region. Semi-structured interviews and
nominal focus groups were conducted to gather qualitative data; quantitative survey data were
also collected. The results revealed factors classified as impacting patients at the individual-level
and systemic level, and others classified as health-related and informational/educational.
Participants ranked insurances issues, limited income, lack of a personal means of transportation,
lack of patient motivation, the number of procedures required to complete the evaluation,
scheduling difficulties and time constraints as top barriers to completing the medical evaluation
process. Top motivators consisted of informational support, social support, religious beliefs,
patients’ desire to get off dialysis, support from the transplant staff, center-based education,
patient’s knowledge of the benefits of transplantation and patient navigators. These findings
provide valuable information on factors that impact AA renal patients’ completion of the medical
evaluation.

Factors Predicting African American Renal Patients’ Completion of the Medical Evaluation
Process for Kidney Transplantation
African Americans are more susceptible to end-stage renal disease (ESRD) as a result of
genetic characteristics and socioeconomic factors such as higher rates of hypertension and
diabetes, both leading causes of kidney disease, differences in antigens (substances which
activate the production of antibodies), income differences and health behaviors (Andrews et al.,
2012; Churak, 2005; Ladin, Rodrigue & Hanto, 2009). According to the United States Renal Data
System (USRDS, 2015), the incidence rate of ESRD was 3 times higher among African Americans
relative to Caucasians in 2013. The prevalence rate of ESRD continues to be highest among
African Americans at 5,584 per million population compared to Whites and Asians at 1,499 and
2,196 per million population respectively (USRDS, 2015). According to the Organ Procurement
and Transplantation Network (OPTN) there are 108, 258 patients in the US on the waitlist in the
hopes of receiving a kidney as of April 1, 2016 (OPTN, 2016). Of the total number of patients on
the waitlist, 36, 456 (33.68%) are African Americans, although they consist of about 13.3% of
the US population (OPTN, 2016; United States Census Bureau, 2016). This disparity in
incidence is also mirrored in the treatment options pursued by African American patients relative
to Caucasians and patients from other racial and ethnic groups.
Treatment options for patients with ESRD include dialysis therapy (i.e., hemodialysis,
peritoneal dialysis) and transplantation, with the latter typically producing better outcomes.
ESRD patients who receive transplants experience less mortality and morbidity and have a better
quality of life in comparison to those who remain on dialysis (Christensen & Ehlers, 2002).
USRDS (2013) data shows that adjusted rates for all-cause mortality for dialysis patients are 6.5
to 6.9 times greater than the general population. In contrast, transplant patients’ adjusted rates
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for all-cause mortality are 1.0 to 1.5 times higher than the general population, indicating
significant benefits of transplantation (USRDS, 2013).
Yet, research comparing African Americans to other ethnic groups indicate lower rates of
transplantation. One explanation is that African Americans are less likely to donate organs than
are individuals of other races/ethnicities (Lunsford et al., 2006) which causes a disparity in the
number of African Americans receiving kidneys relative to other groups. Although there is an
increased need within the African American community, African Americans are less likely to
seek kidney transplantation or complete the medical evaluation for placement on a waitlist for a
transplantable kidney. Alexander and Sehgal (2001) noted that 84% of Blacks expressed a lack of
interest in transplantation and/or were medically unsuitable for kidney transplantation relative to
74% of Whites. Garg, Diener-West and Powe (2001) also reported lower rates of waitlist
placement for Blacks relative to White renal patients. This disparity in placement on the waitlist
appeared to be greatest among younger African Americans and African Americans with fewer
health concerns, who were 50% and 40% less likely to be waitlisted, a finding contrary to
previous findings. However, access to kidney transplantation involves the completion of several
procedural steps not the least of which is a medical evaluation.
The medical evaluation or pre-transplant work up, which requires patients to consult with
doctors and undergo a series of tests and examinations (e.g., chest x-ray, dental exam, cancer
screenings, etc.), is a tedious process and one that often impedes a patient’s ability to be placed
on the waitlist. For some patients, the medical evaluation process may be the first time they learn
about transplantation (Gaston et al., 2003). Successful completion of the medical evaluation
generally leads to transplant candidacy status and placement on the waitlist for a deceased donor
transplant or a living donor transplant in cases where the patient has identified a living donor
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(Weng, Joffe, Feldman, & Mange, 2005). Low rates of completion of the medical evaluation
could contribute to reduced access to transplantation among African American patients with
ESRD (Weng et al., 2005). As a result, these patients must endure sustained dialysis treatments,
which are associated with decreased quality of life, greater dependence on health care providers,
diet restrictions and depression (Christensen & Ehlers, 2002). Alexander and Sehgal (2001)
advocate for reducing barriers during the early steps in the transplant process such as referral and
evaluation in an effort to reduce racial disparities in access to transplantation. An exploration of
the factors that promote and/ or impede the completion of the medical evaluation process is
central to diminishing disparities in access to transplantation between African Americans and
other racial groups such as Whites and Asians.
Several studies have been conducted in an effort to understand why some African
American ESRD patients complete the medical evaluation process, while the majority are unable
to do so. Past research attributes patient and healthcare related factors including physician
recommendation, socioeconomic status (SES), social support and physician beliefs to racial and
ethnic differences in completion of the medical evaluation for transplantation (see Dageforde,
Box, Feurer & Cavanaugh, 2015; Joshi, Gaynor, & Ciancio, 2012; Navaneethn & Singh, 2006).
Given that an examination of the past literature indicates a myriad of factors contributing to
racial differences in executing a pre-transplant work up, the current study examined the factors
that impact medical evaluation completion specifically, the barriers and motivators to completing
the medical evaluation. This study sought to address this phenomenon by examining the
perceptions of transplant center professionals and ESRD patients regarding the factors that
promote and/or hinder completion of the medical evaluation for kidney transplantation among
African American renal patients.

3

Literature Review
End stage renal disease (ESRD)
Chronic kidney disease (CKD) occurs when the kidneys fail to filter the blood properly,
allowing waste products such as excess water and ammonium to build up in the body; the result
is a multitude of health problems including high blood pressure, fluid in the lungs and kidney
failure (Centers for Disease Control and Prevention (CDC), 2014). Risk factors for CKD include
high blood pressure, diabetes, cardiovascular disease, high cholesterol, lupus and a family history
of CKD. People with CKD are susceptible to kidney failure or ESRD (also referred to as Stage 5
CKD), a life-threatening disease (CDC, 2014). Some of the symptoms associated with this
disease include appetite loss, nausea, weight loss, muscle cramps, problems urinating, difficulties
concentrating, and sleep problems (CDC, 2014). The leading causes of kidney failure are
diabetes and hypertension, accounting for 7 of the 10 new cases of ESRD (CDC, 2014). African
Americans are more likely to develop ESRD than Whites which can be accounted for in part by
the higher prevalence of hypertension and diabetes in this population (Klag, et al., 1997; Martins,
Tareen & Norris, 2002). Blacks are also more likely to receive an HIV/AIDS diagnosis which
could cause kidney disease, increasing a person’s likelihood of developing ESRD (Martins et al.,
2002). Black patients tend to develop ESRD at a younger age and incidence rates increase by
age, every ten years of life. They also have the highest rate of hypertension-related ESRD,
surpassing any other racial or ethnic group (Martins et al., 2002). Nonetheless, there are effective
treatments for ESRD with good outcomes.
Treatments for ESRD
Dialysis therapy and kidney transplantation are necessary for survival when diagnosed
with ESRD (CDC, 2014). Dialysis therapy involves the use of an artificial replacement where
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blood is pumped from the body into a filtration device. This device cleans the blood by removing
waste, excess fluid and toxins (USRDS, 1999). Hemodialysis is one form of dialysis treatment
where the patient is connected to a machine which filters waste and water through the circulation
of blood, through an artificial dialyzer also referred to as an “artificial kidney.” The cleaned
blood is then pumped back into the patient’s body (Center for Medicare & Medicare Services
(CMS), 2016; USRDS, 1999). Treatments are typically scheduled three times a week and could
last for three to four hours (USRDS, 1999). Peritoneal dialysis is another form of dialysis
treatment which requires the placement of a catheter into the abdominal cavity and is
accompanied with repeated instillation and drainage of sterile dialysate (cleansing fluid which
removes toxins from the bloodstream) (USRDS, 1999). Both peritoneal and hemodialysis may be
performed at home after a patient and an assistant undergo weeks of training. However,
hemodialysis is typically carried out in dialysis centers (USRDS, 1999). Finally, hemofiltration
which is synonymous to hemodialysis, is used for emergency purposes (Ledebo, 1998). Past
literature indicates that dialysis patients are more likely to be in danger of five-year mortality and
tend to have a poorer quality of life as compared to patients who undergo transplantation
(Waterman et al, 2006; USRDS, 2015).
Kidney transplantation is the preferred treatment option for ESRD given that it is
associated with reduced mortality and morbidity relative to dialysis treatments (Patzer et al.,
2009; Waterman Rodrigue, Purnell, Ladin & Boulware, 2010). The United Network for Organ
Sharing (UNOS) 2012 annual data report for kidneys show ongoing improvements for transplant
recipients over the last 15 years (OPTN/SRTR, 2014), including a decrease in graft failure and
an increase the number of people living after receiving a transplant. As of June 2011, 164, 200
adults in the US survived with a functioning kidney graft which is about twice the rate of
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survival rate ten years ago (OPTN/SRTR, 2014). There are two forms of kidney transplantation:
live donor kidney transplantation and deceased donor kidney transplantation. Regardless of the
route to transplantation chosen, patients risk organ rejection, lifetime use of immunosuppressant
mediations and surgical complications (Serur et al., 2011).
Live donor kidney transplantation (LDKT) occurs when a kidney is donated from a
healthy person, usually a living family member, friend or another altruistic person (Waterman et
al., 2010). LDKT is associated with higher organ survival, better renal function and shorter wait
times, especially since a live donor transplantation can be arranged in three to four months
(Gruessner & Benedetti, 2008; Waterman et al., 2010). Patients are less knowledgeable of
LDKT, hesitant to discuss this option of transplantation with potential donors, and have concerns
about the risks associated with donation, limiting the number of living donor transplants
performed each year (Pradel, Mullins, Bartlett, 2003; Cabrer et al., 2003; Lunsford et al., 2006;
Traino 2014).
Deceased donor transplantation, also referred to as cadaveric or posthumous
transplantation, occurs after a donor’s organs are procured and evaluated for transplantation,
after the person is pronounced brain dead or after the person’s heart is no longer beating
(MacPhee & Fronek, 2012). The benefits of deceased donor transplantation include better quality
of life without having to depend on a machine for survival, and it does not involve the use of a
live donor.
Deceased donor transplantation requires access to a transplant wait list (Gaston et al.,
2003). There has been a historic scarcity of deceased donor organs including kidneys, due to
high demands and limited organs made available for transplantation. The median time for
patients who were enrolled on the waitlist in 2009 was 3.6 years. In 2008, 51% of African
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Americans remained on the waitlist after three years in comparison to 36% of Caucasians
(USRDS, 2013, 2015). Although there are about 108, 258 renal patients on the waitlist in hopes
of receiving a transplantable kidney, only 1,447 transplants have been performed this year.
African American transplant recipients make up a small fraction of this number given that only
390 (26.95%) African American patients have received transplantable kidneys (OPTN, 2016).
Pre-transplant Medical Evaluation
Placement on the transplant waitlist requires patients to meet certain criteria and complete
numerous tests to assess transplant suitability. The medical evaluation for transplantation aims to
identify contraindications that would preclude transplantation and to make rectifications where
necessary in order to maximize a patient’s odds of a successful transplant (Gruessner &
Benedetti, 2008). The pre-transplant work up also provides an opportunity to educate the patient
about the transplantation process given that the potential recipient meets and interacts with
several members of the transplant team (Gruessner & Benedetti, 2008). The first part of the
medical evaluation begins with consultations and interviews with a number of transplant
professionals such as nephrologists, transplant coordinators, social workers although there may
be a few variations depending on the transplant center (Gruessner & Benedetti, 2008; Ortiz,
Manzarbeitia & Zaki 2002).
The purpose of the consultation is to gather a comprehensive history and provide a
physical examination. An emphasis is placed on the etiology of the progression of the disease,
the amount of time spent on dialysis, vascular access history and problems, urine production, and
the occurrence of urologic issues such as neurogenic bladder (a condition which causes a person
to lose control of their bladder). Additional emphasis is placed on medications and an
examination of systems to detect unique extrarenal organ system complications (Ortiz et al.,
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2002). Furthermore, the patient’s ability to tolerate exercise as well as discussions about how
previous infections may compromise the transplantation are addressed (MacPhee & Fronek,
2012). Laboratory testing, x-rays and other procedures are also performed. Some of the required
tests include human leukocyte antigen (HLA; proteins found on white blood cells that help a
person’s immune system detect differences between healthy body tissues and foreign
substances); blood typing to match a kidney to the transplant candidate; chest x-rays; coagulation
screens; mammograms for women over 40 years old; and, electrocardiograms (EKG) (Gruessner
& Benedetti, 2008; MacPhee & Fronek, 2012). Immunizations for Hepatitis B, influenza, and
among others are updated as needed (Gruessner & Benedetti, 2008).
Psychosocial evaluations are performed where a social worker evaluates prospective
candidates who are then referred to a psychologist or psychiatrist if significant psychological
concerns come to light (McGrath & Rubin, 2012). Additionally, extensive laboratory, radiologic
and specialty tests (e.g., endoscopy, colectomy, and liver biopsy) are performed (McGrath &
Rubin, 2012). Elderly patients are presented with separate challenges since they are more likely
to develop infections and malignancy may be prevalent, reducing their overall life expectancy
(MacPhee & Fronek, 2012). Patients with comorbidities face additional challenges since this
increases the number of tests needed to complete the evaluation (Danovitch, Cohen & Smits,
2004). After completing this process, the patient’s information and tests are reviewed by a
multidisciplinary team who determine whether the patient is suitable for placement on the
national waitlist. The patient must also be financially cleared (Ortiz et al., 2002). The pretransplant process could take up to a year to complete with recent studies indicating that patients
have a median referral to listing time anywhere from 46 days to 226 days (Norris, 2014). Racial
differences in completing the medical evaluation process are evident indicating Blacks are less
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likely to complete the process or take longer to complete the process in comparison to Whites
(Alexander, Ashwini & Sehgal, 1998; Patzer et al., 2012).
African Americans and Kidney Transplantation
Several studies have investigated African American beliefs and health behaviors
surrounding kidney transplantation. A plethora of reasons account for the problems this racial
group faces in accessing renal transplantation. One major reason for the inequality in the pursuit
of kidney transplantation is lower rates of organ donation among Blacks which could be
influenced by several factors such as a lack of awareness, attitudes towards donation and medical
mistrust (Churak, 2005; Moore, 2007; Whaley, 2001). Immunological incompatibility of
deceased donor kidneys, lower rates of referral, limited access to healthcare, less desire for
kidney transplantation, and socioeconomic factors such as health insurance, (see Boulware et al.,
2005; Hall, Choi, Xu, O’Hare & Chertow, 2011; Held, Pualy, Bovbjerg, Newmann &
Salvatierra, 1988) also influence patients’ desire to seek or attain transplantation. These barriers
may occur during different components of the transplantation process including the medical
evaluation.
Organ donation among Blacks
Blacks display lower rates of organ donation relative to other racial groups (Ariola,
Perryman & Doldren, 2005; Ariola, Perryman, Doldren, Warren & Robinson, 2007; Held et al.,
1988). Moore (2007) reported that when families are approached to donate organs or tissues of
their death relatives, African American families are less likely to respond. OPTN data indicates
that of the 767 deceased donor kidneys donated in 2016, 126 were from African Americans in
comparison to 511 from Whites. Similarly, fewer living donor kidney organs were donated from
African Americans (32 of 425 total organs) relative to Whites (310 out of 425) (OPTN, 2016). At
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first glance these statistics may lead one to believe that African Americans are less altruistic than
other racial groups, particularly Whites. However, past studies indicated that African Americans
are very charitable and contribute a larger percentage of their income to charities and churches in
comparison to Caucasians (Moore, 2007). This suggests that other factors may account for the
low organ donation rates among Blacks. The difference in organ donation could be attributed to
lack of knowledge about the need for organs, attitudes and distrust of the medical system,
concerns about the fairness of the allocation system, religious beliefs including certain
misconceptions and socioeconomic factors such as problems with insurance. These reduced
donation rates could contribute to the health disparities in obtaining kidney transplants (Ariola et
al., 2005).
Many Blacks are unaware of the growing need for renal organs in the African American
community. Blacks are also less likely to know someone who has donated an organ or signed up
to become a donor (see Churak, 2005; Joshi et al., 2012). Moore (2007) highlighted the
importance of increasing awareness of the need for organs in the African American community
given that the lack of awareness places African Americans at a disadvantage for life saving
treatments. Results from study of 311 African American adults whose attitudes towards organ
donation were examined indicated that people who engaged in family discussions about donation
were more knowledgeable of organ donation and had more favorable attitudes towards donation
(Morgan, 2004). This suggests that one reason for the low rates of donation among African
Americans is a lack of awareness of the need. Therefore, increasing awareness among this
population could result in better donation rates.
A number of common misconceptions about donation could also account for the disparities
in donation among Blacks and Whites. For example, many Blacks believe that signing the donor
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card would result in reduced medical care and an early declaration of death without provision of
all the medical help available (Ariola et al., 2005). This could be a result of a general distrust of
the medical community. Mistrust of the medical system and health care professionals by Blacks
may be attributed to the historical exploitation of Blacks such as the sterilization of African
American women and abuse during hospitalization (Churak, 2005). One of the most popular
examples of the exploitation of Blacks is during the Tuskegee Syphilis study in which
researchers funded by the federal government withheld treatment from the African American
male participants (Boulware, Cooper, Ratner, Laveist & Powe, 2003). Consequently, African
Americans who are aware of historic events of discrimination and/or have personal accounts of
exploitation in the healthcare system are more likely to be wary of the medical community
(Corbie-Smith, Thomas, Williams & Moody-Ayers, 1997). Previous studies found out that
Blacks who are suspicious of Whites may terminate psychotherapy because they think they will
be seen by a White counselor, and they perceive the healthcare facility to be governed by Whites
(Terrell & Terrell, 1984). Many Blacks do not trust that doctors have their best interests in mind
and as a result avoid routine checkups (Churak 2005; Moore, 2007). Terrell and colleagues
(2004) found that Blacks who are suspicious of Whites are less willing to consent to either
donating their own organs or agreeing to the recovery of organs from relatives (Terrell, Mosley,
Terrell & Nickerson, 2004). An analogous study found that Blacks who were distrustful of
hospitals and had concerns about discrimination explained some of the variability in willingness
to donate (Boulware et al., 2002). This distrust of the medical system is likely to impede access
to kidney transplantation since African Americans may believe doctors do not have their best
interest in mind. Hence, they may be hesitant to complete the pre-transplant work up since this
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would mean more interactions with doctors and with an increasingly complex and confusing
healthcare system.
Factors that impact access to kidney donation
Organ allocation and matching also have roles in African American views on kidney
transplantation. Some African Americans are skeptical about donation due to apprehensions
about race and class-based inequalities in the distribution of organs (Ariola et al., 2005) which
could be a result of the uncertainty that the health care system is working in their favor. The
current allocation system gives priority to people in the same geographic region versus those
most in need. Posthumous transplantation generally favors patients living in closest proximity to
the transplant center, which suggests that waitlisted candidates living farthest from transplant
centers are less likely to receive a transplant (Axelrod et al., 2010). Universal criteria for
candidate selection have yet to be established hence, individual transplant centers create their
own medical criteria. This increases the chances that a patient who is listed at one center may be
regarded as less critical at another center with more rigorous medical criteria (Moore, 2007).
Biological factors such as immunological incompatibility also result in lower rates of
kidney transplantation among Blacks (Boulware et al., 2005). Organ allocation practices take
into consideration certain biological characteristics of both the recipient and the donor to
enhance graft survival. Differences in the expression of HLA antigens are more likely to occur
among people with different racial backgrounds. Therefore, the organ allocation system attempts
to match patient recipients to donors with similar expressions of HLA antigens (i.e., the same
racial and ethnic background). Although this practice is less emphasized in recent years due to
the introduction of improved immunosuppressants, recipients and donors must still possess
significant biological similarities. Therefore, since most of the transplantable kidneys available
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are from White donors, this reduces matching rates for Blacks (Churak, 2005; Joshi et al., 2012).
Racial differences in ABO blood type indicate that African Americans are more likely to have
blood type O which places them at a disadvantage since this blood type has a reduced likelihood
of kidney transplantation according to UNOS requirements for ABO identity between donor and
recipient (Churak, 2005), resulting in longer wait times. OPTN data shows that between 20032004, the median wait time for African Americans waiting for a kidney was about 1831 days (5
years). This varied for Whites who had a median wait time of 1310 days (3.5years) (OPTN,
2016). Arguably, knowledge of the potential drawbacks to procuring a transplantable organ
based on an individual’s racial status may prevent Blacks from pursuing transplantation as a
treatment option, and prevent people from donating their kidneys.
Religious beliefs regarding the desecration of the body and a desire to keep the human
body in good condition for the afterlife also impact African Americans’ attitudes toward organ
donation (Ariola et al., 2005; Held et al., 1988). This belief system could be attributed to JudeoChristian religious attitudes which state that the body must be kept whole on judgment day
(Moore, 2007). Boulware and colleagues (2002) found that spirituality and religion accounted
for most of the difference observed in willingness to donate for Black men and women relative to
Whites (Boulware et al., 2002). A qualitative study by Thompson (1993) revealed that many
African Americans believe they need their organs for resurrection in order to bring their death to
completion, although participants noted that religious beliefs did not have an impact on their
decision to donate. Some African Americans continue to hold certain religious misconceptions
about donation although all major religions such as Christians, Amish, Buddhism and Hinduism
support and encourage organ donation (Gallagher, 1998). Some researchers advocate for the
inclusion of the clergy and utilization of altruistic values in Christian beliefs to promote donation
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(Ariola et al., 2005; Boulware et al., 2002). The impact of religious beliefs is substantial to
Blacks’ ability to pursue transplantation and serves as another barrier to organ donation and the
procurement of transplantable kidneys.
Socioeconomic factors such as income, education and insurance status affect
transplantation accessibility. These factors impact the distribution of wealth, power and
opportunities among people (see Churak, 2005; Joshi et al., 2012), making it difficult for some
people to access the best services and treatment. Patients who are listed on the transplant waitlist
tend to be well-educated, employed and have health insurance particularly private insurance
(Churak 2005; Coorey, Paykin, Singleton & Gaston 2009; Joshi et al., 2012; Soucie, Neylan &
McClean, 1992). Income alters treatments choices given that patients with more money can seek
superior treatments including specialty services, and have better access to transportation
(Axelrod et al., 2010; Held et al., 1988). People from low socioeconomic backgrounds, many of
whom are Black, tend to be less educated and thus have less awareness of the benefits of renal
transplantation (Naveneethn & Singh, 2006). Subsequently, these patients may exhibit poor
medical compliance (Naveneethn & Singh, 2006), further reducing their likelihood of seeking
transplantation. ERSD patients without insurance or with limited insurance show a reduced
likelihood of maintaining doctors’ appointments since they may have concerns about costs and
payments (Churak, 2005). Some research suggests that African Americans are in favor of
financial reimbursement for deceased donor’s funeral expenses, cash payments to deceased
donor’s families or estates, cash payments to deceased donor’s charity of choice, tax breaks for
deceased donor’s families, and reimbursement of deceased medical expenses after adjustments,
among other compensations. Nonetheless, these public incentives have been debated with
strongly voiced objections to such compensations (Boulware, Troll, Wang & Powe, 2006).
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It is apparent that kidney transplantation for African Americans is influenced by a
myriad of factors which may affect their beliefs about donation, their knowledge of
transplantation and their ability to obtain transplantable organs. Nonetheless, should ESRD
patients decide to seek a medical evaluation, it is necessary to understand the factors that may
facilitate or impede their success.
Factors that positively impact completion of the medical evaluation for kidney
transplantation
Weng and colleagues (2005) proposed that social networks could improve pre-transplant
work up completion rates since patients with previous knowledge about transplantation
facilitated by their family and/or friends, may be prone to perceive transplantation as a viable
treatment option. In a study of both patient attendees and non-attendees of the initial visit for a
medical evaluation, Dageforde and colleagues (2015) found a relationship between attendance
and patient’s reported knowledge of transplantation. Churak (2005) advocated for increasing
patient social networks among African Americans to become more heterogeneous since this
could increase access to information about the benefits of kidney transplantation. Consequently,
this could propel Black ESRD patients to complete the evaluation process.
According to Clark, Hicks, Keogh, Epstein and Ayanian (2008), the medical evaluation
can be difficult to finish when a patient has clinical and social problems. As their study revealed,
increases in levels of instrumental support networks was connected to better completion rates
among Black women, after examining Black and White ESRD patients who had started dialysis
in four regional networks. The authors recommend the use of instrumental social support to
assist with tasks such as cooking, cleaning, scheduling appointments, navigating health care
systems, and child care in order to help patients pursue and complete diagnostic evaluations
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(Clark et al., 2008). Supplemental private insurance was noted as a possible motivator for
completing pre-transplant work ups among Black men (Clark et al., 2008). Garg and colleagues
(2001) further advocated for an intervention which targets young Black men to reduce the
disparity in transplant activation. This is because young Black men are less likely to be listed for
a transplantable organ although they have a better chance of survival because they may have
fewer health problems aside from renal disease (Garg, Diener-West & Powe, 2001).
Support from physicians and healthcare professionals can be advantageous to Blacks
completing the medical evaluation. Black patients were more likely to complete the medical
evaluation when their physicians appeared to be invested in their care and expressed a preference
for transplantation (Clark et al., 2008). Other recommendations for improving kidney
transplantation access include minority education about renal disease, post–secondary education,
media promotion, emotional support and counseling, more diverse clinicians, and ongoing
encouragement during the transplant process (Churak, 2005; Moore, 2007).
Navigators, health care providers who educate patients and guide them through the
medical system, can also be helpful in assisting ESRD patients through the medical evaluation
process (Sullivan et al., 2012). A study which implemented an intervention with navigators
reported that patients completed the transplant steps faster than the control group without
navigators (Sullivan et al., 2012). This shows the potential of faster pre-transplant work up
completion when patients are educated and supported throughout the process. Additionally,
social networking websites have been found to be useful for helping kidney patients provide
information about transplantation and solicit living donors (Chang, Anderson, Turner, Shoham,
Hou & Grams, 2013). The literature provides some suggestions and presents minimal study
findings regarding the factors which facilitate the completion of the medical evaluation
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suggesting that this is an area for more research. See Table 1 for a compiled list of proposed
factors that positively impact patients’ completion of the medical evaluation for transplantation.
Table 1
Facilitators of Medical Evaluation Completion
Factor

Study

Accessible or free transportation

Churak, 2005

Diverse clinicians

Churak, 2005

Education of minority groups about renal disease

Churak, 2005

Emotional support and counseling

Churak, 2005

Knowledge about transplantation

Dageforde et al., 2015

Instrumental support with tasks such as cooking and

Clark et al., 2008

cleaning
Interventions targeted towards Black men

Garg et al., 2001

Media promotion

Moore, 2007

Navigators

Sullivan et al., 2012

Physician investment

Clark et al., 2008

Private insurance

Clark et al., 2008

Post-secondary education

Moore, 2007

Social networks to facilitate knowledge about

Churak, 2005; Weng et al., 2005

transplantation
Social networking websites

Chang et al., 2013
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Factors that negatively impact completion of the medical evaluation for kidney
transplantation
Patient-related elements like socioeconomic status (i.e.; unemployment, lack of health
insurance, poverty), comorbid illnesses which in turn increase the number of tests a person has to
undergo during the evaluation, and beliefs about transplantation delay the completion of the pretransplant workup (Danovitch et al., 2004; Navaneethn & Singh, 2006; Weng et al., 2005). A
study by Weng and colleagues (2005) examined rates of completion of 175 patients who were
undergoing the pre-transplant work up for a kidney transplantation. Findings indicated that
Blacks were less likely to complete the medical evaluation; failure to complete the process was
associated with more comorbidities, which likely slowed the process due to the additional
medical tests needed to confirm candidacy. Synonymous findings were reported by Danovich
and colleagues (2004) who found that patients with more complex illnesses had prolonged or
incomplete workups. Patients who first heard about transplantation from their nurses or doctors
reported a reduced likelihood in completion of their pre-transplant work up. Weng and
colleagues (2005) attributed this to patients’ lack of close relations to educate them about
transplantation (Weng et al., 2005). Thus, the lack of prior knowledge about the medical
evaluation for transplantation serves as a barrier to completing the process.
Another study examining 2,291 patients referred for medical evaluation (1,486 Blacks
and 805 Whites) reported higher rates of incompletion of the requirements for evaluation among
Blacks relative to Whites (45.7 vs 17.9) (Patzer et al. 2012). Blacks in this study were less likely
to have health insurance and more likely to live in poor neighborhoods. Socioeconomic factors
such as insurance, education, employment, distance, neighborhood poverty and degree of rurality
accounted for some of the variability in completing several transplant steps such as starting
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evaluation, completing evaluation and being waitlisted. Indeed, patients with higher
socioeconomic status progressed faster through the transplant steps (Patzer et al. 2012). In
contrast, patients with low SES often delay seeking medical care and specialty services which
results in delayed referrals to regional transplant centers, evaluations, and enrollment on the
waitlist (Axelrod et al., 2010). Patients who initiate the medical evaluation for kidney
transplantation report concerns related to finding a living donor, and concerns about the cost of
the medical evaluation, transplant operation, transportation and medications. Furthermore, those
who are listed at other transplant centers may be less compelled to complete their evaluation due
to transportation difficulties (Dageforde et al., 2015). These findings provide support for the
impact of socioeconomic factors in the completion of the pre-transplant work up.
Other patient-related factors also affect the completion of the medical evaluation.
Distance from the transplant center is another factor that has been discussed in the literature and
shown to delay the medical evaluation process. Blacks living in rural areas are inclined to
experience transportation problems in their attempts to get to the transplant center, impeding
placement on the waitlist (Danovich et al. 2004; O’Hare, Johansen & Rodriguez, 2006). Dialysis
status could also reduce a patient’s ability to complete the pre-transplant work up since dialysis
patients may be less motivated to seek transplantation. This could be attributed to a number of
reasons such as feeling sick after using the dialysis machine and patient’s perception that he or
she is functioning well on dialysis. Hospitalizations and the navigation of complications
associated with dialysis therapy could also hinder progression through the medical evaluation
(Weng et al., 2005). Furthermore, extended dialysis use makes it harder to have a successful
transplant given that it increases the patient’s susceptibility to other illnesses and poor physical
health, reducing the chances of receiving a transplantable kidney. Consequently, since the
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majority of Black ESRD patients are on dialysis, this reduces their ability to finish the pretransplant work (Weng et al., 2005). Also, findings from Clark and colleagues (2008) show that
renal patients who perceive the dialysis and patient support staff as important to their treatment
are less likely to complete pre-transplant workup (Clark et al., 2008). It is possible that these
patients wish to maintain the relationship they have with the dialysis staff and are thus reluctant
to pursue transplantation since dialysis becomes a part of their socialization. Blacks are less
likely to recognize potential benefits of transplantation, less likely to be referred, and are referred
later than Whites, increasing the likelihood that they have already initiated dialysis therapy
before considering transplantation as a treatment option (Alexander et al., 1998; Rodrigue,
Cornell, Kaplan & Howard, 2008). Therefore, it is critically important that the patients who
present at a transplant center for evaluation complete the pre-transplant work up to get listed.
Healthcare-related barriers linked to medical evaluation completion revolve around racial
discrimination and difficulties in the physician-patient relationship. Reports of racial
discrimination by African American patients reduces their desire to seek transplantation given
that they have to go to unfamiliar healthcare settings (Klassen, Hall, Saksvig, Curbow &
Klassen, 2002). Victims of discrimination anticipate poorer outcomes and expect to be treated
poorly which makes them reluctant to access new treatment settings. According to Klassen et al.,
(2002), most African Americans report more positive racial relationships in dialysis centers
which reduces their desire to seek new treatment facilities.
The role of the physician is very important in motivating patients to pursue
transplantation. Doctors are less likely to provide Blacks with information about transplantation
relative to White patients (Kasiske, London & Ellison, 1998; Joshi et al., 2012). Healthcare
professionals may consciously or unconsciously discriminate against disadvantaged people,
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many of whom are African American and turn out to be medically non-adherent, resulting in
barriers to placement on the waitlist (Kasiske, London & Ellison, 1998). Blacks are prone to
remain on the waitlist for long periods of time and have a reduced likelihood of receiving an
organ in comparison to Whites (Callender & Miles, 2004). Hence, Black patients with an
awareness of their reduced chances of obtaining a kidney transplant could be deterred from
completing the medical evaluation.
Lower referral rates impact the initiation of the pre-transplant work up, creating problems
for African Americans seeking renal transplantation (Alexander & Sehgal, 1999; Joshi et al.,
2012). This could be attributed to factors such as less interest in transplantation and physicians’
beliefs about transplantation (Alexander & Sehgal, 1999; Ayanian et al., 2004). Doctors may be
less likely to view transplantation as a superior treatment for Black ESRD patients in comparison
to Whites, although they perceive transplantation to improve the quality of life for ESRD
patients over dialysis therapy (Ayanian et al., 2004). In cases where nephrologists practiced in
two or more dialysis facilities, Blacks reported receiving less information or no information
about transplantation than Whites (Ayanian et al., 2004). Reports indicate that Blacks have better
outcomes on dialysis, which could lead to the misconception that kidney transplantation may not
be appropriate or not needed for them (Churak, 2005). Health literacy, a concept used to the
explain a patient’s capacity to navigate the health care system either by understanding medical
terminology or services in order to make informed decisions about one’s health, has been linked
to the accessibility of kidney transplantation (Grubbs, Gregorich, Perez-Stable & Hsu, 2009).
Low health literacy has been shown to produce poorer health outcomes and health care
consumption. A study by Grubbs and colleagues (2009) indicated that inadequate health literacy
was associated with lower rates of referrals among 45 Black patients and 17 White patients
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receiving hemodialysis (Grubbs et al., 2009). Taken together, past research indicates several
barriers in accessing transplantation among African Americans. Refer to Table 2 for a compiled
list of factors that negatively impact the completion of the medical evaluation.
Table 2
Impediments to Medical Evaluation Completion
Factor

Study

Being listed at different transplant centers

Dageforde et al., 2015

Comorbidity which results in additional testing

Danovich et al., 2004; Weng et al., 2005

Concerns about finding a living donor

Dageforde et al., 2015

Dialysis status

Weng et al., 2005

Dialysis center as main form of social support

Clark et al., 2008

Distance from the transplant center

Danovich et al., 2004; O’Hare et al., 2006

First knowledge of transplantation from nurses or

Weng et al., 2005

doctors
Lack of health insurance

Patzer et al., 2012

Late referrals or fewer referrals from doctors

Alexander & Sehgal, 1999; Joshi et al., 2012;
Rodrigue et al., 2008

Less knowledge about the potential benefits of

Alexander & Sehgal, 1999

transplantation
Limited health literacy

Grubbs et al., 2009

Low SES

Axelrod et al., 2010; Navaneethn & Singh, 2006;
Patzer et al. 2012
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Physician beliefs about transplantation

Ayanian et al., 2004

Reports of racial discrimination

Kassike et al., 1998; Klassen et al., 2002

Theoretical Framework
The Health Beliefs Model was used as a guide in understanding factors that impact
kidney patients’ completion of the medical evaluation process. Developed in the 1950s, the
Health Beliefs Model was used to explain the utilization of health services. The model proposes
that an individual would be more likely to use health promotion strategies to avoid or manage a
disease based on the person’s perception of their susceptibility and the severity of the disease.
Additionally, the individual is more likely to engage in efforts to avoid or reduce the severity of
the disease assuming these strategies are useful and not accompanied with barriers such as costs,
convenience and pain (Rosenstock, 1974). Variations in perceived susceptibility of a disease or
illness may range from complete denial to perceiving the illness as a serious threat to the
individual’s physical health. An individual’s perception of the severity of an illness may be
determined by both psychological and physical consequences of the illness. For example,
concerns that the illness may be deadly and/or cause psychological impairment or negatively
impact the individual’s social functioning. Accepting one’s susceptibility to an illness may
promote taking action to prevent or manage the disease which is in turn influenced by the
individual’s perception of the costs and benefits associated with taking that action. Hence, the
individual is more likely to engage in preventive health behaviors or treatment when
susceptibility or the severity of the illness can be reduced. Psychosocial and economic factors
such as the impact on the family unit, personal motivation, level of psychological distress, and
expenses also play a role in whether the individual chooses to engage in the health behavior.
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Internal or external cues to action (e.g., personal realization of the individual’s health status,
education about the illness, family encouragement to engage in health behavior) may further
propel the person to engage in the health behavior (Rosenstock, 1974). Specific to kidney
transplantation, patients’ decision to complete the medical evaluation may be influenced by
perceptions of susceptibility to more adverse outcomes such as death, either from stay on
prolonged dialysis or from the surgical procedure for transplantation, and the severity of their
illness (e.g., some patients’ health may have significantly deteriorated due to prolonged dialysis
use or due to other comorbidities). Additionally, patients may base their decision to complete the
evaluation process on the costs and benefits of transplantation. For example, patients who rely on
dialysis centers as their main source of support may be less inclined to complete the medical
evaluation process; whereas those who see the adverse effects of prolonged dialysis use may be
more inclined to finish the process. Further, cues to action such as education about the benefits of
kidney transplantation may encourage some patients to complete their evaluation. Figure 1
provides a representation of how this model may be used to understand factors that impact
completion of the medical evaluation.
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Perceived susceptibility
to adverse health
outcomes (e.g.,
prolonged dialysis use
resulting in poor health)

Demographic variables (e.g.,
gender, age)
Psychosocial variables (e.g.,
denial of disease, lack of
familiarity with renal disease in
social network)
Structural variables
(e.g. knowledge of ESRD or the
benefits of transplantation)

Perceived benefits
(e.g., desire to get off dialysis,
better quality of life)
minus
Perceived barriers
(e.g., insurance issues, low SES)

Perceived threat of renal failure
(or prolonged dialysis use)

Likelihood of completion
the medical evaluation

Cues to action
(e.g., accessible or free
transportation, comprehensive
insurance, education about
the benefits of transplantation,
navigators)

Figure 1. Hypothetical demonstration of the Health Beliefs Model to understand factors that are
likely to impact completion of the medical evaluation for kidney transplantation.
Statement of Problem
As revealed in the discussion above, past research highlights a variety of factors that
impact African American ESRD patients’ ability to access kidney transplantation. However,
there is no clear consensus as to which factors facilitate and hinder the pre-transplant work up in
order to have patients registered on the transplant waitlist. Thus, further investigation is
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warranted regarding the pre-transplant work up process in order to help reduce disparities in
access to transplantation.
This study explored the views of transplant professionals and ESRD patients regarding
barriers and facilitators to completion of the medical evaluation for kidney transplantation. The
purpose of this study was to determine specific factors that predict completion of the medical
evaluation by identifying the most significant barriers and motivators. The findings may provide
insight that could lead to systemic changes to improve rates of completion of the medical
evaluation process for African Americans. Subsequently, understanding barriers and motivators
to completing the medical evaluation will serve to fulfil the needs of patients, in order to reduce
health disparities between African Americans and other racial groups. Recent studies have
accessed physician beliefs about transplantation accessibility but no study to date has assessed
transplant professionals’ views of the factors that impact the completion of the medical
evaluation. This study sought to extend the literature by providing a comprehensive view on the
medical evaluation process by examining African American ESRD patients and different
transplant professionals such as nephrologists, transplant coordinators and social workers, all of
whom are integral to the completion of the pre-transplant work up. This will provide a thorough
understanding of the facilitators and barriers to initiating and completing the pre-transplant work
up. The use of a mixed methods approach serves to shed light on this phenomenon as the
qualitative and quantitative approaches complement each other, and provide a detailed portrait of
the most important factors impacting completion of the medical evaluation for Black ESRD
patients.
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Study Aims
The present study sought to identify the factors that impact the completion of the medical
evaluation process for kidney transplantation among African American ESRD patients. It is
guided by the following overarching questions:
1. What factors facilitate and impede the initiation and completion of the medical evaluation
process for kidney transplantation?
2. What are the most significant factors to initiating and completing the medical evaluation
process?
Aim 1: To identify barriers and motivators to completing the evaluation process as perceived by
transplant professionals.
Research Question (RQ) 1: What are the barriers to renal patients’ completion of transplant
evaluations as perceived by transplant professionals (e.g., nephrologists, coordinators, social
workers)?
RQ 2: What factors motivate patients to complete the transplant evaluation process as perceived
by transplant professionals (e.g., nephrologists, coordinators, social workers)?
RQ3: Are there differences in perceptions of the motivators and barriers by transplant
professionals (e.g. differences between nephrologists, coordinators and social workers)?
Aim 2: To identify the most significant barriers and motivators to completing the transplant
evaluation process as perceived by ESRD patients by incorporating the list of barriers and
motivators solicited by the transplant professionals
RQ 4: What barriers do patients cite as impediments to completing the evaluation for
transplantation?
RQ 5: What factors facilitate patients’ completion of transplantation evaluations?
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RQ 6: How do patients rank the barriers to completing the medical evaluation for
transplantation?
RQ 7: How do patients rank the motivators to completing the medical evaluation for
transplantation?
Aim 3: To identify differences in perceptions of the factors that impact the completion of the
medical evaluation process as determined by patients and transplant professionals.
RQ 8: How do rankings differ between patients who have completed the process (Status 1 and/or
2) and patients who have not (Status 7)?
RQ 9: How do rankings differ between patients and transplant professionals?
Method
This study applied a mixed-methods design to examine factors associated with
completion of the medical evaluation process for kidney transplantation. The two phases of the
proposed study utilize both qualitative and quantitative data collection methods through the use
of focus groups with a nominal group technique (NGT) and semi-structured interviews, as well
as survey data with participant ratings. All phases of the study were approved by the
Institutional Review Board (IRB) at Virginia Commonwealth University (# HM20001313).
Phase I
Participants
The first phase of the study consisted of semi-structured interviews with a stratified
purposeful sample of transplant professionals (N =23). Purposeful sampling aims to gather
information rich cases for a thorough examination of a phenomenon (Patton, 1990). Specifically,
stratified purposeful sampling helps illustrate the characteristics of particular subgroups and
creates an avenue for making group comparisons (Patton, 1990). Participants consisted of
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nephrologists (n = 6), transplant coordinators (n = 8), social workers (n = 6), psychologists (n =
2), and a transplant nurse practitioner (n =1). The majority of transplant professionals were
female (n=16; 69.6%) self-identifying as Asian (8.7%), Black/African American (13.0%), and
the majority as White (78.3%). On average, these professionals had 10.24 (SD = 8.65) years’
experience working with transplant patients undergoing the medical evaluation process. The
majority of these professionals had a medical degree (34.8%) or master’s degree (34.8%), and
the rest had some graduate training (4.3%) or a bachelor’s degree (26.1%).
Procedure
Participants were recruited from nine transplant centers in the Mid-Atlantic, Mid-Western
and Southeastern regions of the United States. They were invited to participate in the study via
phone or email correspondence, listservs, letters and through word of mouth or snowballing
techniques (e.g., other transplant professionals informing potential participants about the study).
Data collection took place over a five-month period from September 2014 to January 2015.
Semi-structured interviews were used for data collection. The interviews were digitally audiorecorded and lasted approximately 60 minutes; all interviews were conducted by the principal
investigator, a middle-age Black woman in a private room. At the beginning of each interview,
participants were provided with information about the structure of the interview and verbal
informed consent was obtained from all participants before recording the interview. Nine
interviews were conducted in person and 14 were held via telephone to maximize enrollment in
the study. Additionally, participants were asked to complete a survey capturing demographic
information and questions assessing participants’ ratings of factors that impact the medical
evaluation process. Participants were compensated with a $5 Starbucks gift card as gratitude for
participating in the study.
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Semi-structured Interviews
Semi-structured interviews allow for the collection of comprehensive information about
participants’ perceptions of the factors associated with completion of the medical evaluation
process. This form of data collection facilitates the expression of thoughts, feelings and attitudes
in a private setting. Semi-structured interviews usually consist of observations of behavioral
patterns, casual and unstructured interviewing. Open-ended questions provide some structure and
also allow for gathering different ways of perceiving the topic discussed (Cohen & Crabtree,
2006). Some of the questions included in interview are: 1) How long does it take the average
patient to complete the evaluation process? 2) What individual-level factors impede patients’
completion of the evaluation process? 3) What would you recommend to help African American
patients, specifically, complete the medical evaluation process and reduce disparities in this
aspect of transplantation? (Refer to Appendix A for a complete description of the questions). The
semi-structured interview was initially pilot tested by the principal investigator and her
supervisor (HMT) prior to recruitment. The structure of the protocol and some of the initial
questions were edited after the pilot test and feedback received from the first four participants.
The addition of several open-ended questions and probes helped ensure a thorough examination
of the issue. The information gathered on barriers and motivators to completing the medical
evaluation process was incorporated into the second phase of the study.
Quantitative Measures
In addition to the interviews, participants were asked to complete a brief quantitative
survey (paper or online version via SurveyMonkey.com). The survey was designed to elicit
ratings of the potential barriers and motivators to patients’ completion of the medical evaluation
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process as identified in the extant literature. A copy of the survey is provided in Appendix B and
the specific measures included are described below.
Perceived barriers. Ten 7-point Likert-type questions were used to assess perceived
barriers to completing the medical evaluation process. Specifically, respondents were asked to
indicate the extent to which each potential barrier impacted patients’ completion of the medical
evaluation along a 7-point scale (1-Not at all /7-Strongly impacts). These questions were
developed for this study and informed by the past literature on proposed barriers to completing
the medical evaluation process. Individual items were summed to create a global measure of
perceived barriers (Cronbach’s alpha (α) = 0.84).
Perceived motivators. Two 7-point Likert-type questions, informed by the past literature
on proposed motivators to completing the medical evaluation process were used to assess
transplant professionals’ perceptions of their impact on the medical evaluation process (1-Not at
all/7-Extremely positive impact). The first question measured navigators as a motivator for
completing the medical evaluation process (i.e. how much would navigators impact an African
American patient’s ability to complete the medical evaluation process?) and the second question
measured instrumental support (i.e. how much would instrumental support impact an African
American patient’s ability to complete the medical evaluation process?).
Demographic information. Demographic information was also collected (e.g., years of
education, racial/ethnic background and type of occupation).
Phase II
Participants
The second phase of the study consisted of purposeful sample of African American renal
patients (N = 30). Patients who have completed the medical evaluation process are assigned a
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status of 1 or 2. Status 1 patients have been cleared for a transplant, and could receive a call for a
transplantable kidney at any time. Status 2 patients have also been cleared but their need for an
organ may not be as urgent as a Status 1 patient. Status 7 patients are those who have not
completed the pre-transplant work up or those who have been added to the transplant list but are
not yet cleared due to medical, financial or psychosocial reasons (Pham, Pham, Pham, Pham &
Pam, 2011). To secure a full understanding of the motivators and barriers, ESRD patients with a
Status 1 assignment (n = 10) and Status 7 patients (n = 20) who had not completed the pretransplant workup at the time of enrollment were recruited. The study sought to recruit equal
numbers of patients who had completed the medical evaluation and those who had not. However,
recruitment yielded more Status 7 patients, which is preferred given that one of the main goals of
the study is to identify barriers to completing the medical evaluation process.
Participants consisted of Black/African Americans (100%) with 21 (70%) men and 9
women (30%) and a mean age of 49.79 (SD = 8.57). The majority of patients were single
(33.3%) or married/cohabited (33.3%) and the remaining were divorced (23.3%), separated
(3.3%) or widowed (6.7%). Participants’ identified their religious affiliation as Protestant (60%),
Catholic (13.3%), Other (13.3%, including people who identified as non-denominational and
Jehovah’s witness), and four patients did not report a religious affiliation (13.3%). Twelve
patients (40%) had a high school education or less and another twelve patients (40%) had an
Associate’s degree or some college. Six patients had a Bachelor’s degree (10%) or some
graduate training/Master’s degree (10%). Most of the patients (53.3%) had an annual household
income of less than $20, 000, eight patients had an annual household income of less than
$40,000, two reported that their household income was less than $60,000 and the rest (10%) had
an income of $60,000 or more. One person did not report their income.
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Procedure
Participants were recruited from one Mid-Atlantic transplant center in the United States
from which the principal investigator obtained a list of African American patients who had either
completed the medical evaluation or were in the process of doing so. Potential participants were
mailed a letter inviting participation in the study. They were then contacted via telephone to
solicit questions and invite participation; patients expressing interest were scheduled to attend
one 90-minute focus group interview. Data collection took place over a ten-month period from
March 2015 to December 2015. Refer to Figure 1 for a complete description of the data
collection methods by study phase.
Due to the high no-show rate, both in-person semi-structured interviews (n =8) and focus
groups (n = 22) were used for data collection. For example, five patients would be scheduled for
a focus group and one patient would show up. Consequently, semi-structured interviews were
conducted in place of a focus group when there was only one patient present. The focus group
moderator’s guide was initially pilot tested by the principal investigator and research assistants
prior to recruitment. The focus groups (or semi-structured interviews) were conducted in a
private room conference (with a whiteboard) located in an office building of a local university.
The focus groups were digitally audio-recorded and lasted between one to two hours (semistructured interviews last about thirty); all interviews were moderated by the principal
investigator (PI), a middle-age Black woman and co-moderated by a research assistant, who
made observations and took notes. The racial/ ethnic backgrounds of the co-moderators (research
assistants) included Asian (n =1), Black/African American (n =3), Hispanic (n =1) and White (n
=2). At the beginning of each focus group interview, participants were provided with focus group
guidelines (e.g. confidentiality and use of first names only or pseudonyms; Appendices C & D).
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A total of nine focus groups were conducted that ranged in size from two to four participants;
three (n =2), two (n =3), one (n =4) Status 7, and three (n =2) Status 1.
The last two questions of the focus group applied a nominal group technique which
required participants to rate the most significant barriers and motivators to completing the
medical evaluation individually and together as a group. Patients were given the option to
incorporate information gathered from transplant professionals from phase I (i.e. a list of barriers
and motivators) before finalizing their group rankings. At the end of each focus group or semistructured interview, participants were asked to complete a paper survey which included
demographic information and questions assessing participants’ ratings of factors that impact the
medical evaluation process (See Appendix E). Light refreshments were provided during each
session, and participants were compensated with a $20 visa gift card as gratitude for their
participation.
Phase One
(Transplant professionals)

Phase Two
(ESRD patients)

Semi-structured
interviews
(N = 23)

Focus groups with ESRD patients
(N = 30)

Status 1 / 2
(n = 10)

Nephrologists, Coordinators, Social workers
(n = 6)
(n = 8)
(n = 6)
Psychologists, Transplant Nurse Practitioner
(n = 2)
(n = 1)

Figure 2. Data Collection by Phase
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Status 7
(n = 20)

Focus group with Nominal group technique (NGT)
Focus groups are a data collection technique that facilitate group interaction (Ashbury,
1995). A highly structured focus group with a nominal group technique (NGT) was used to
gather information about the phenomenon under investigation (Morton, Tong, Webster, Snelling
& Howard, 2011). Focus groups with an application of a nominal group technique (NGT)
employ a group process in which members work independently within the presence of others to
yield quantitative data that are then explained by the qualitative component (Delp, Thesen,
Motiwalla & Seshardi, 1977). Subsequently, group members interact with each other to discuss
ideas generated throughout the process. Finally, participants weigh the ideas generated against
others, and rank-order the items on a scale of importance (Delp et al., 1977). NGTs allow for the
solicitation of views from interviewees, and provide a means of gathering information from each
group member on predetermined questions. Additionally, it provides two forms of output; a list
of items relevant to the topic (for this study the output will be factors that are associated with the
completion of the medical evaluation), and quantified individual and collective measures of the
items identified (Delamere, Wankel & Hinch, 2001). The qualitative data generated provides a
rationale for why participants rank certain items as being most and least important (Corner et al.,
2007). Developed by Van de Vaen and Delbecq (1972), NGTs prevent interviewees from
tailoring their answers to the interviewer’s nonverbal responses (Porter, 2013). This technique
facilitates the prioritization of ideas (Harvey & Holmes, 2012) which in this study would be
ranking the factors with the greatest impact on patients’ completion of the medical evaluation
process.
In a typical focus group with NGT, the moderator poses a question to the group and each
member writes down as many ideas as possible. The moderator asks each group to share the
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ideas generated, which is written on a flip chart for all group members to see. Discussions do not
occur until each member has shared their ideas. The ideas generated are then discussed together
and as a group. Finally, group members prioritize the most important items or ideas. The
outcome is a mathematical cumulative of individual member preferences to provide group
rankings (Delp et al., 1977). Modified from the NGT used by Corner and colleagues (2007), the
focus group interviews conducted in the current study began with introductory questions and
transition questions, before key questions were asked using the nominal group technique (Corner
et al., 2007).
NGTs have been applied in health research and have been used to identify areas of
priority in research (Corner et al., 2007). This technique has been used in several studies by the
National Institutes of Health (NIH) since 1977 to gather information on different health related
topics (Fink, Kosecoff, Chassin & Brook, 1984). NGTs have also been applied to research in
educational settings, social service and government organizations (Fink et al., 1984). Morton
and colleagues (2011) used the NGT as a mixed methods approach to gather characteristics of
dialysis important to patients and family caregivers (Morton et al., 2011).
For example, Status 1 patients were asked: 1) What are some things that made it easier to
complete the medical evaluation process for kidney transplantation? 2) What are some things
which made it difficult to complete the medical evaluation process? Questions posed to Status 7
were modified as appropriate and included: 1) What are some things which have made it difficult
to complete the medical evaluation process? 2) What do you think will help you complete the
medical evaluation process for kidney transplantation? Open-ended questions and the use of
probes were used to prompt participants to elaborate on or provide more detail about their
responses. The full moderator’s guides are provided in Appendices C & D.
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Quantitative Measures
The same questionnaire administered to the transplant professionals in phase I was
administered to patients in Phase II. The patient version of the demographic questions had
additional patient-specific questions such as health insurance status and distance from the
patient’s house to the transplant center (see Appendix E).
Data Analysis
Qualitative analysis
Information from the semi-structured interviews and focus groups were audio-recorded,
de-identified, and transcribed verbatim by a research assistant. The transcripts were then
reviewed by another research assistant and edited as needed, to ensure that the information had
been accurately transcribed. Consequently, the transcripts were uploaded into MAXQDA 11, a
qualitative and mixed-methods software for data analysis.
Grounded theory. Grounded theory was used as a theoretical paradigm for assessing the
qualitative data gathered in Phases I and II. This theory is particularly advantageous for
analyzing qualitative data since it has the potential to lead to the development of a theory
(Creswell, 2007) , which would to explain relationships between and among factors that facilitate
or impede the completion of the pre-transplant work up. According to Strauss and Corbin (1998),
grounded theory brings awareness to and offers a meaningful guide to action which enhances
understanding of a phenomenon (Strauss & Corbin, 1998). This theory uses constant
comparative analysis where the data is coded into categories and then recoded to develop
themes, leading to the development a theory (Birks & Mills, 2011; Glaser & Strass, 2012).
Rigorous coding procedures such as open coding, axial coding and selective coding guide the
analyses to derive meaning from the data (Strauss & Corbin, 1998).
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Open coding utilizes an analytic process to generate concepts in relation to their
properties and dimensions. During open coding, data is broken down into discrete parts, closely
examined, and compared for similarities and differences (Strauss & Corbin, 1998). Events,
happenings and/or actions which are conceptually synonymous are grouped under more abstract
concepts called categories (Strauss & Corbin, 1998). Specifically, this study reviewed the
responses from each discussion topic generated from the semi-structured and focus group
interviews to assign code names. These codes were then used to produce major categories and
subcategories. A preliminary coding scheme was developed by the PI through open coding in
MAXQDA 11. Consequently, a coding manual was developed with clear definitions for each
code. New codes were included under an Other category for further examination, discussion and
categorization. Three research assistants also coded the data to facilitate inter-coder reliability
(i.e. transcriptions were divided among research assistants for coding whereas the PI coded all
transcriptions). All team members created their own projects in MAXQDA.
Axial coding was used as the next step in the coding process, wherein categories are
related to their subcategories along the lines of their properties and dimensions. This process
aims to determine how categories crosscut and link (Strauss & Corbin, 1998). During this stage
of the coding process, the data is assessed in new ways and responses generated are compared to
each other. Finally, selective coding was performed to integrate the categories and refine them
(Strauss & Corbin, 1998). This whole process involved a constant comparative analysis, as
transcribed responses were compared to each other and themes emerged from the data.
Information gathered from the interviewer/moderator notes during the semi-structured interviews
and focus groups were also incorporated into the analyses. Data saturation was achieved when no
new themes emerged from participants’ responses.
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Trustworthiness. Trustworthiness is a way to increase rigor in qualitative studies and to
assess the value of findings (Krefting, 1991). Specific strategies must be implemented to avoid
possible threats and to test the validity (credibility) and reliability (dependability) of findings
(Krefting, 1991; Maxwell, 2013). Verbatim transcripts of the semi-structured interviews and
focus groups facilitated the collection of rich, detailed data, and provide a complete portrait of
the phenomenon under investigation (Maxwell, 2013). Credibility and dependability was
demonstrated through triangulation, which involves the use of a diverse sample and different
data collection methods (Krefting, 1991; Maxwell, 2013). To facilitate triangulation, this study
utilized semi-structured interviews and focus group interviews and recruited different transplant
professionals, as well as patients at different points in the pre-transplant work-up. Further, the
interviewer/moderator notes were also incorporated into the data analysis. Reflexivity, which is
an assessment of the influence of a researcher’s background and perceptions of the research
process (Krefting, 1991), is another strategy used to demonstrate credibility and was
implemented in the current study. The PI kept a log to reflect on her experiences and
methodological issues that arose during the research process. The PI and RAs also processed
their experience of the focus group interviews and discussed group dynamics. As indicated by
Maxwell (2013), these memos helped the PI develop a more thorough understanding of the topic,
study and setting. Furthermore, dependability was established through peer examination where
the PI discussed the findings with impartial colleagues specifically, other graduate students and
faculty with expertise in qualitative research design. These colleagues checked the categories as
developed and assessed disconfirming cases (Krefting, 1991).
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Quantitative Analysis
The quantitative data gathered from the surveys were entered into the statistical program,
SPSS Version 23 (IBM Corporation, 2015), by the PI. Descriptive statistics such as means and
standard deviations were calculated to characterize the transplant professional and patient
samples. Given the small sample size of the study, and that the data did not meet the stringent
assumptions of its parametric equivalent (Pallant, 2010; Rovai, Baker & Ponton, 2013), the
Students t-test for independent samples (Levene’s test p >.05), the Mann-Whitney U was the
preferred analytic approach for examining differences in perceived barriers and motivators to
completing the medical evaluation process.
Priority scores were calculated from the top five barriers and motivators (first = 5 points,
second = 4 points, third = 3 points etc.) to completing the medical evaluation generated through
NGT and summed across all focus groups and semi-structured interviews. The data was then
presented as a percentage of the maximum possible priority score (number of participants
completing rankings multiplied by 5 points) (Sanderson, Morris, Calnan, Richards, Hewlett,
2010; Morton et al., 2011). The data for the group consensus of the top barriers and motivators
was displayed as a percentage of the weighted total score (Locke et al., 2015).
Power Calculation. The G*Power statistical software (Faul, Erdfelder, Lang, &
Buchner, 2007) was used to develop a priori power analyses to determine the most appropriate
sample size for analyzing associations between perceived barriers and motivators. Power
analysis for correlations using α = .05 criterion for achieving an 80% chance of detecting a largesized effect yielded the most conservative sample size estimate (N = 13). The total number of
participants (N = 53) recruited for the study was above sample estimates for conducting the chisquare tests and correlations. Given that the total sample size was small, A Mann U Whitney test
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was used to examine differences in perceived barriers and motivators between transplant
professionals in place of the parametric equivalent, an independent groups t test.
Results
Descriptive Statistics
Means, standard deviations, and counts were calculated for transplant professional and
patient characteristics (see Table 3). Certain demographic data was not gathered given that not
all questions were applicable to both subpopulations.

Table 3
Sample characteristics
Variable Name

Total
(N=53)

Age
Gender
Male
Race
Asian
African American
White
Occupation
Nephrologists
Transplant Coordinators
Social Workers
Psychologists
Transplant Nurse Practitioner
Education
High or less
Associate’s degree/Some college
Bachelor’s degree
Some graduate/Master’s degree
Doctorate/Medical degree
Years of Experience
Marital Status
Single/Never married
Married/Cohabit
Divorced
Separated
Widowed

Transplant Professionals
(n=23)
*

Patients
(n=30)
49.79 (SD =8.57)

7 (30.4)

21(70)

2 (8.7)
3 (13)
18(78.3)

*
30 (100)
*

6 (26.1)
8 (34.8)
6 (26.1)
2 (8.7)
1 (4.3)

*
*
*
*
*

*
*
6 (26.1)
9 (39.1)
8 (34.8)
10.24 (SD =8.65)

12(40)
12(40)
3 (10)
3 (10)
*
*

*
*
*
*
*

10(33.3)
10(33.3)
7 (23.3)
1 (3.3)
2 (6.7)
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Religious Affiliation
Protestant
*
18(60)
Catholic
*
4 (13.3)
Other
*
4 (13.3)
Not reported
*
4 (13.3)
Annual Household Income
$0 - $19,000
*
16(53.3)
$20,000-39,999
*
8 (26.7)
$40,000-59,999
*
2 (6.7)
$60,000+
*
3 (10)
Not reported
*
1 (3.3)
Patient Perception of Completion1
Yes
*
18 (60)
No
*
12 (40)
Patient Health Insurance Status
Yes
*
29(96.7)
No
*
1 (3.3)
Distance to transplant Center (miles)
*
12.54 (SD =8.15)
Transportation
Yes
*
29(96.7)
Car Share
*
1 (3.3)
1
Note. Patient perception of completion indicates patient’s perception of whether they have
completed the medical evaluation or not. Values are expressed as count (percentage) unless
noted otherwise.
Thematic Analyses
Transplant Professionals’ Identified Barriers to Completion of the Medical Evaluation
Thematic analyses were conducted to address RQ1, namely, identifying transplant
professionals’ perceptions of barriers to patients completing the medical evaluation. These
themes are presented here, in descending order, beginning with most frequently reported barriers.
Theme 1: Individual-level barriers. Transplant professionals most often reported
barriers that impact the patient at the individual level. The majority of these barriers consisted of
socioeconomic impediments such as limited income, insurance issues and limited social support,
personality characteristics such as personal motivation and fears, and belief systems such as
medical mistrust or religious beliefs.
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Subtheme (a): Socioeconomic barriers. Patients with limited income have a difficult time
covering the costs associated with medication (e.g., immunosuppressants and steroids) and
transportation. Insurance issues such as difficulty covering the necessary co-pays and frustrations
with navigating insurance paperwork fall into this category. Additionally, those with limited
social support experience barriers in completing the medical evaluation, resulting from lack of
emotional support as well as difficulties with transportation and childcare. Examples of
socioeconomic barriers are reflected in the following quotes from participating transplant
professionals:
Transplant Nephrologist: “Uh, biggest one is poorness. I mean that's it. I mean that's...
Whether you're white or black, it doesn't really matter. But if you’re poor, you’re not
going to, you have a less likelihood of having support, and having, you know,
transportation, having all that stuff that you need to have to, uh, to complete the
evaluation.”

Transplant Coordinator: “Um, lower socioeconomic patients who don’t have the
Medicaid full, the full Medicaid for transportation, and medications. Um, they’re going to take a
while to get things done. Just because they don’t have the resources they need.”

Transplant Coordinator: “Um, transportation can sometimes be a problem because a lot
of the people who are on dialysis do not drive and they are reliant on other people to drive them
so those people have to take time off work to do that.”
Subtheme (b): Beliefs systems. Patients who do not believe that healthcare professionals
have their best interest in mind or those with concerns about discrimination are less likely to
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complete the pre-transplant workup. This is exacerbated by the fact that patients are asked to
provide a thorough medical, psychosocial and financial history, consequently increasing their
interactions with healthcare professionals. Transplant professionals noted that some patients with
religious beliefs perceive the outcome of their illness to be in “God’s hands” or are cautious
about seeking living donation. The following quotes reflect this subtheme:
Social Worker: “Um, I think sometimes male patients in particular, um, and certainly
middle-aged African-American men often, um, I think are a little bit tougher to, um,
connect with, or in the sense that, in the way that I work with them as a social worker, I
think sometimes they’re a bit distrusting with me and the questions that I have to ask and
the things we have to go over.”

Transplant Coordinator: “I think that sometimes people that are African American or
even Hispanic if they’re hearing the message that we can’t move forward with transplant
or there’s a barrier, occasionally, not very often, we will be told by that recipient, “well
you don’t want to do this because I’m Black or because I’m Mexican.”

Psychologist: “Actually, the times that that has come up it has been in African American
patients. The times that either has been a belief that they will get healed; that they don’t
need a transplant because a miracle will happen and they will get healed; um, or that
they’ve stopped taking their medicine because they believed that God was going, that you
know, God would protect them and they didn’t need to take their medication ‘cause God
would heal them and make that kidney work. Um, those, those specific cases, and it’s
only been a handful, have been in African American patients.”
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Subtheme (c): Other individual-level barriers. Professionals also viewed patients who are
unmotivated or passive as being less likely to complete the pre-transplant workup. According to
the professionals interviewed, patients may be overwhelmed by the process, have fears about
losing their benefits or making several hospital visits, and/or be afraid of the surgical procedure
for transplant. Other patients may be less prepared for their appointments and may not have the
appropriate paperwork. For example, a nephrologist reported, “…. Some people are just afraid of
coming to a major hospital and navigating the corridors the hallways, uh, it’s the feeling of the
unknown that they have to go through a surgery, uh, which might be a problem if they think,
‘Okay, I’m on dialysis why do I need this big surgery….’”
Theme 2: Informational/educational barriers: Barriers related to a patient’s lack of
knowledge of the medical evaluation process, transplantation, and/or kidney disease were also
cited by transplant professionals. Additionally, gaps in information provided to patients or gaps
in patients’ formal education may impede comprehension of said information. These
informational/educational barriers were the second most commonly identified type of barrier to
completing the medical evaluation.
Subtheme (a): Limitations in formal education. Several professionals reported that
patients with limited formal education display challenges with literacy or comprehension of
reading materials. For example, a transplant coordinator stated, “…If they’re not able to read all
the information that we give them in the booklets or they don’t look it up on their own, I think
that does play a factor into whether or not they complete their evaluation because they may not
understand the importance of it.” Another transplant coordinator shared:
“Um, that seems to be an issue sometimes, they just, some people just don’t seem to
really get it, you know, understand why it’s important or why they’re going to benefit

45

from it. Um, and I guess you do see that kind of more often in people that don’t have as,
as high of an education level.”
Subtheme (b): Access to information about transplantation. Transplant professionals
reported that some patients do not have access to information about transplantation. They may
not have access to the Internet to read about transplantation or they are unable to access
information about transplantation from their social networks. Other patients may not know how
to obtain information about transplantation or kidney disease. A transplant coordinator reported:
“Um, possibly more so with the older ones I guess because, you know, they don’t have
the computer skills that younger people do. You know, younger people it doesn’t matter
what ethnicity, you know what I’m trying to say. Um, you know, they know about
computers and how to look for information if they wanted and I guess maybe because we
do have a higher, uh, percentage of African Americans that you do see that more
commonly with them, especially in the older ones that don’t surf the web and, you know,
look up information.”
Subtheme (c): Transplant education. Many transplant professionals discussed the fact
that patients are presented with high volumes of information during their evaluation and the
information is not always catered to their understanding. An example of this can be seen in this
excerpt from a transplant coordinator: “…They receive a lot of education on their first visit and
no one could humanly really retain all of that so as coordinators we do kind of follow up.”
Subtheme (d): Limited knowledge of the medical evaluation and/or transplantation.
Patients without knowledge of the benefits of transplantation over sustained dialysis or those
who do not know the purpose of the medical evaluation process face barriers in completing their
evaluation. This is reflected by the following quote from a nephrologist: “… Yeah, I think
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understanding the importance of the test and understanding where they are in the transplant
process and why they have to complete the tests, and the benefits of transplants.”
Theme 3: Systemic barriers. Systemic barriers, or barriers at the hospital level, were the
third most frequently identified barrier to patients’ completion of the medical evaluation for
transplantation. Transplant professionals reported that patients experience these barriers because
of referral processes and scheduling difficulties, and struggle to navigate their way around a
large hospital.
Subtheme (a): Healthcare logistics. Patients have a difficult time navigating the
healthcare system including finding a doctor’s office or trying to find their way around large,
complex hospital campuses. One social worker speculated that navigating unfamiliar hospital
settings may be intimidating for patients: “…um, the hospital, uh, a large university hospital in
the inner city can be very intimidating for them.”
Subtheme (b): Transplant-specific problems. Some patients are not referred for transplant
or there is a delayed referral by their general nephrologist. Since there is no central testing
location, patients must attend several doctors’ appointments, sometimes at different locations.
Scheduling multiple appointments around ongoing dialysis treatments presents additional
difficulties. Further confusion arises when breakdowns in communication between the transplant
professionals and patients occurs. A nephrologist stated, “…Uh they’ll see different providers
even in their own facilities, different nephrologists…they might not get referred early so they
might develop a lot more disease by the time they get to see us…”
Theme 4: Health-related barriers. Health-related barriers were the fourth most named
barrier to completion of the medical evaluation process. Barriers that fall under this category
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include the patient presenting with multiple health conditions or comorbidities; prolonged
dialysis use, which may make the patient more ill; and weight issues.
Subtheme (a) Comorbidities. Patients with multiple health conditions, in addition to
ESRD (e.g., cardiovascular disease), experience delays because considerably more tests are
required to progress through the evaluation process. In some instances, patients must also be
deemed clear of the condition before being allowed to complete the evaluation process. A
transplant coordinator stated:
“Um, heart disease, if they have, um, severe heart disease. Um, calcification in the
vessels where the kidney would attach that could prevent someone from being able to
receive a transplant. Um, you know we just have to make sure that in general they’re
going to become better, not worse, from the transplant. So if they have multiple
comorbidities it may not be a good idea for them. So, a lot of times it’s heart disease.”
Subtheme (b) Health status. Dialysis is a physically demanding therapy leaving many
patients exhausted and physically ill, limiting the ability to keep appointments as scheduled.
Further, prolonged dialysis is associated with both physical and psychological problems such as
fatigue, depression, decreased quality of life and heart disease (Christensen & Ehlers, 2002,
Heerspink et al., 2009; Jhamb, Weisbord, Steel & Unruh, 2008). In general, most ESRD patients
have poor health because of their disease. This excerpt from a transplant coordinator exemplifies
this subtheme:
“So, because if somebody isn’t feeling well then that, that person might just say, you
know, I can’t go to (transplant center) today and sit there for, like, three hours. That’s
health status, and it can, but it can mean a lot of different things, as much as, you know,
not feeling well. But there could also be complications, um, with dialysis. You know
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maybe they have, they’re planning to do dialysis early in the morning and something
went wrong.”
Subtheme (c): Health requirements. Patients with BMI above 30 are required to lose
weight before being released to complete the medical evaluation. Similarly, patients with severe
mental illness and substance use may be required to seek treatment, be medically stable, or be
drug free before they can complete the evaluation. A nephrologist reported:
“Um, I think if people aren’t being properly treated for their mental health issues they
don’t… I think mental health, you have to come back and meet with a psychiatrist as well
too, with an extra layer to it. Um, and if someone’s depressed, then they don’t want to go
to their test. And so, I think it’s untreated mental health, let me re-phrase that. Um, and
then the other thing is substance abuse you know. I think that’s a major impediment. You
have these functional drug abusers as well. People who use cocaine but are still
functional, to the sense that, I mean, functional in a sense that they have End Stage Renal
Disease and cocaine probably contributed to it but they’re not, you know, they’re still
married, they still live in a house, they have kids who want to donate kidneys to them but
keep coming back positive for cocaine. Well, you know, they’re the model dialysis
patients, that all their labs are perfect, they never miss a dialysis treatment, but they keep
getting disqualified because of their positive drug, and even marijuana as well too, and a
lot of patients use marijuana to help them with the nausea associated with the dialysis, so
that becomes it, but those are really the major two things…”
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Patient-identified Barriers to Completion of the Medical Evaluation
Thematic analyses were conducted to address RQ4: identifying patients’ perceptions of
barriers to completing the medical evaluation process. These themes are presented here, in
descending order, beginning with most frequently reported barriers.
Theme 1: Individual-level barriers. Similar to transplant professionals, patients were
most likely to report individual-level barriers. The majority of these barriers were socioeconomic
in nature, such as limited income, impacting the cost of medications and access to transportation.
Additionally, insurance issues and limited social support were indicated as contributing to
socioeconomic difficulties. Some patients also mentioned time constraints in trying to fit their
medical appointments in with their dialysis schedule and other activities such as work and
childcare. Further, difficulties finding a living donor also served as a barrier. Some patients
reported that lack of motivation or fears (e.g., about losing benefits after transplant, undergoing
the transplant surgery) impede completion of the medical evaluation process. A few patients
attributed difficulties in completing the evaluation process to medical mistrust. The following
excerpts reflect this theme:
Male patient: “…That’s one things I have a problem with, if I go through with the
transplant, that’s the only things I’m going to have problem with all my appointments because
my mother doesn't drive, my two sisters refuse to drive in the city because they two country girls.
They will not drive in (city), and I don’t think I'm going to be able to drive so I have to find
somebody to bring me back and forth.”
Male patient: “…As far as with you, man, when I get my transplant I don’t got nobody to
take care of me. Um, how can I get some assistance with this, you know what I'm saying?
Because I'm by myself …”
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Female patient: “…You know there’s, um, the financial aspect of it, um, of getting a
transplant, the funding of it, um, you know because even with insurance you still, um well,
sometimes if you have insurance and social security or Medicare then usually you’re pretty good
but there’s a copay if you just have insurance so it’s still a big financial responsibility that you
end up…”
Female patient: “…Well, you have to make sure the donor is a match obviously. Um, and
it’s hard to get a donor. No one wants to go through it and, um, uh it’s just a hard process…”
Male patient: “… like you get a kidney and you’re off disability but what if I'm just not
ready. Ok, and then nobody says ok, and I know how things work because they’ll say, well, you
got a kidney and you’re fine, well, ok you’re saying I'm fine but what if I’m not fine you know
who’s to make that judgment to say your finances should be cut off…”
Theme 2: Systemic barriers: In contrast to transplant professionals, systemic barriers
were the second most commonly identified barrier among patients. The barriers were mostly
transplant-specific problems that related to poor communication between the patients and
transplant staff; scheduling difficulties; having to work with several doctors; long wait times for
doctor’s appointments and test results; and, not having access to transplant coordinators. Further,
some patients also reported systemic barriers related to healthcare logistics such as difficulty
finding their way around the hospital, parking issues, and construction. The following examples
illustrate this theme:
Female patient: “It takes a long time for some of them, some people have to have sleep
studies, it could take you up to four months to get an appointment for a sleep study, so it’s a lot
of stuff and there is a check list, so you have to get this done.”
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Male patient: “…The transplant coordinators, they aren’t very communicative, that’s the
one part I would probably say could use some improving. I mean, I’ve called them sometimes
just to find out where things are and, um, many times I haven’t got a call back, um, from
them…I know they are probably busy but they could do a little more communicating…”
Female patient: “It’s a lengthy process to actually get onto the transplant list.”
Male patient: “…uh, the only thing I, it was just hard finding my way around (hospital).
They had a parking deck that I end up going backward...”
Theme 3: Health-related barriers: Health-related barriers were the third most identified
barriers to completing the medication evaluation by patients. Patients reported subthemes related
to having health conditions other than kidney disease, health status, and health requirements.
Some patients also reported being fatigued, while others mentioned that they had not been
cleared from psychiatry. The quotations below reflect this theme:
Female patient: “Well mine’s is not just a kidney, uh, disease. Um, I guess you could
kinda say I have another illness. Um, my illness is, I don’t know if you ever heard of it,
it’s called tubular sclerosis. And I think I got the complex, which means like the tumors
that’s on my face, it grows on my kidney. And that’s what the doctor, uh, was sayin’ and
that the tumors had grew on my kidney where was messing with the function of my
kidney. So, you know, those two is kinda, you know, together.”

Female patient: “I would say I am really tired all the time, like never before. I just don’t
have energy to do too much of anything. Tired and also with all the medication I take
‘cause I have a chronic hypertension problem so I am on, like, five different blood
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pressure meds… But I just don’t feel like doing anything anymore. That’s the worst part
of all of this. I lay down a lot.”
Male patient: “Mine is fatigue, my energy level is not what it used to be, you know, um,
and I guess, like, from a mental stand point one of the things that, uh, kind of messed
with me is, you know…”
Female patient: “Um, my problem was with the psychiatry because I’ve been under stress
and not only from that but other stuff and I had to go every week, every Tuesday. I got a
lot of problems from fibromyalgia so I don’t sleep at night, I take a lot of medication for
it but I be in a lot of pain so …9’oclock every Tuesday, they had me going to psychiatry
and I just stopped going.”
Theme 4: Informational/educational barriers. Limited information/education was the
fourth most reported barrier to completing the medical evaluation. Patients expressed that they
would have liked more information about transplantation, especially the medical evaluation
process, the number of tests and medical procedures required, and the financial aspects of getting
a transplant. The following quotes exemplify this theme:
Male patient: “Um, well, I wish they would have, um, or somebody would have told me a
little bit more ‘cause, be honest, I didn’t know nothing about tests and stuff. All they just
told me is that I am on the list, and um, be ready when they call me, you know. If I get a
transplant. And you know, that was it. They didn’t really give me much information and,
you know, they should have told me that I had to go through tests and stuff.”
Female participant: “We don’t know all of the procedures that need to be done so we
can’t make that call as to, okay, what needs to be done? You know, it’s ever changing.
You know. If you need more blood work, let us know. You know, because the worse

53

thing is you come up here for an appointment, procedure or whatever, and they say, ‘Oh,
Ms. X, you haven’t had this done. Why weren’t you here for this appointment?’ And you
had no idea it was there. You know. You don’t want to be surprised.”
Transplant Professionals’ Identified Motivators to Completion of the Medical evaluation
RQ2 was addressed by identifying transplant professionals’ perceptions of motivators,
encompassed by the following themes:
Theme 1: System-level motivators. The majority of the motivators identified were
system-level. Transplant professionals indicated that specific structural changes in the hospital
and transplantation system could impact African Americans’ completion positively. The
facilitators include: greater referrals from local nephrologists; patient navigators and/or case
management staff; physician repertoire (i.e., the physician’s ability to build rapport with the
patient); compressed time frame for medical testing; and comprehensive insurance for patients.
A nephrologist commented that, “I think removing the intimidation aspect of things that comes
with the medical system. Trying to work, and I think this goes across racial barriers, trying to
work with their schedule rather than imposing, this must be done by this day and stuff like
that…”
Theme 2: Informational/educational motivators. The second most identified motivator
reported by transplant professionals were informational/educational factors. These include
center-based education about the evaluation process, formal education, presenting information in
lay terms, education of nephrologists, promotion of transplantation, and continued education
about transplantation. One nephrologist stated, “Constant education of the patient so far as the
patient’s education and comprehension level, you want the patient to be able to comprehend
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really quickly as to why they’re not taking their medication and sometimes if they don’t but as
long as you lay out the guidelines, they’ll still be okay as long as they follow your instructions.”
Theme 3: Individual-level motivators. The third most reported type of motivator
identified by transplant professionals impacted patients at the individual level. These include
patients’ desire to get off dialysis and have a better quality of life, patients’ religious beliefs or
faith, and knowledge of a successful transplant recipient. The following excerpt from a transplant
professional reflects this theme:
“…they also see that in their dialysis unit, you know, people are dying or getting their
limbs amputated and they don’t want to be in that situation. They also see patients in the
dialysis unit getting a kidney transplant coming back to dialysis unit doing well after a
kidney transplant, so that is a big motivating factor for a lot of patients. I think the
number one motivation is, the number one answer I get is that I can’t deal with dialysis
anymore, but I think they do realize though because it just drains you so much, they can’t
do anything else the rest of the day. But they also realize the health benefits to that…”
Solutions identified by transplant professionals. Solutions proposed by transplant
professionals include: removing intimidating factors in transplantation, better case management,
comprehensive insurance, improving access to primary care, pre-dialysis treatment, working
with the patients to problem solve, creating programs to motivate or empower patients, and more
education about transplantation and the evaluation process.
Patient-identified Motivators to Completion of the Medical Evaluation
To address RQ5, themes representing patient-identified motivators to completing the
medical evaluation were grouped into the categories below.
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Theme 1: Individual-level motivators. The majority of the motivators identified were
individual-level facilitators to transplant completion. Included in this category was family
support, such as financial support from family members, support from the transplant staff,
patients’ desire to get off dialysis, and belief systems such as spiritual or religious beliefs. The
following quotes illustrate this theme:
Female patient: “… My co-pay was $853 a month, and at the end, the last six months it
was almost $900 a month, however, because God is good, and I have a good brother, he actually
paid my co-pay for me for a total of a little over $10,000 over a 18-month period because I was
unemployed, no income…”
Male patient: “…I mean, if it wasn’t for my wife, I give her all the praise for, uh, pushing
me to go to my appointments and, you know, doing everything I was supposed to, it makes the
process a lot easier…you need somebody.”
Male patient: “Maybe providing transportation…”
Theme 2: Systemic motivators. The second most identified type of motivator to
completing the medical evaluation was systemic. These included good communication with the
transplant coordinators, updates on the patient’s position on the waitlist, appointment reminders,
decreasing the intervals between doctor’s appointments, and rehabilitation support for patients
without social support. This theme is evident in the following quote given by a female patient:
“… I mean, the coordinators have folks to help them (patients) too. They have financial
coordinator and a social worker. Their own staff that works for the transplant office. You
know, and both of those folks can help you if you have financial issues to get your
medication or to get your transplant. And it’s a good thing to do to talk to them before to
see what your financial outlook looks like as far as, you know, even with insurance.”
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Theme 3: Informational/educational motivators. Patients reported
informational/educational motivators least frequently. These include education about
transplantation, specifically the medical evaluation, providing information that is easy to
understand, and knowing a successful transplant recipient. This lack of information is embodied
in the response of one male patient, “Yeah, yeah, I guess if they expect you…why these number
of tests are being done in order to get on the list...you know, why do you need to test that many
to get on the list...um, I guess.”
Group Differences in Identified Barriers
Group differences among transplant professionals’ identified barriers. To help
address RQ3, differences in transplant professionals’ perceptions of barriers were examined.
Specific to barriers, nephrologists reported the most barriers to completing the medical
evaluation process in comparison to transplant coordinators, social workers, and psychologists.
Social workers and psychologists were more likely to address the psychosocial factors associated
with completion of the medical evaluation, such as problems with social support, financial
barriers and problems with substance use or severe mental illness. Nephrologists and transplant
coordinators were also more likely to report individual-level barriers relative to transplant
coordinators, social workers, and psychologists.
Status differences among patients’ identified barriers. To help address RQ8, Status 1
and Status 7 patients’ reports of barriers were compared. Status 1 patients reported fewer barriers
to completing their evaluation and at times had difficulty identifying any roadblocks as
compared to Status 7 patients.
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Group Differences in Identified Motivators
Group differences among transplant professionals’ identified motivators. To help
address RQ3, group differences in perception of motivators by the different types of transplant
professionals were examined. Nephrologists were more likely to report systemic and individuallevel motivators relative to transplant coordinators, social workers, and psychologists. In
contrast, transplant coordinators were more likely to propose information/educational-related
solutions whereas nephrologists proposed systemic solutions. Social workers and psychologists
reported more socioeconomic solutions to completing the medical evaluation process in
comparison to the other professionals.
Status differences among patients’ identified motivators. To help address RQ8,
differences between Status 1 and Status 7 patients’ reports of motivators were examined. Status 1
patients reported more social support, no transportation difficulties, and minor insurance issues.
Both groups reported support from the transplant staff.
Rankings for Barriers to Completing the Medical Evaluation
Twenty-one barriers reported by transplant professionals were prioritized as impeding
completion of the medical evaluation process to help address RQ1. These barriers were further
categorized into individual-level, systemic, health-related and informational/educational barriers.
The majority of the barriers (42.86%) prioritized impact the patient at the individual level and
consisted primarily of socioeconomic difficulties. Six informational/education level barriers
(28.57%), four systemic barriers (19.05%), one health-related barrier (4.76%), and another was
categorized as both a health and systemic barrier (4.76%). The top five barriers identified were:
limited income/low SES, lack of a personal means of transportation, limited/lack of patient
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motivation, insurance issues, and the number of procedures and/or tests required to complete the
evaluation (see Table 4).
To address RQ6, for patients, 36 barriers were ranked and assigned priority scores, with
individual-level barriers (44.44%), systemic barriers (33.33%) and health-related barriers
(11.11%), informational/educational barriers (5.56%), one classified as both a health and
systemic barrier (2.78%), and another as both an individual-level and systemic barrier (2.78%).
The highest ranked barriers were insurance issues, scheduling difficulties, lack of a personal
means of transportation, time constraints that make it difficult to complete several medical
procedures/tests, and limited income/low SES (see Table 5).

Table 4
Transplant Professionals’ Rankings of Barriers to Completing the Medical Evaluation
______________________________________________________________________________
Top Barriers
Total
Max Priority n of
Score
Score (%)
participants
ranking this
their Top 5
1. Limited income/Low SESa
2. Lack of personal means of transportationa
3. Limited/ lack of patient motivationa
4. Insurance issuesa
5. Number of procedures and/tests required to
complete the evaluationcd
6. Multiple health conditionsd
7. Lack of understanding of the informationb
provided during the medical evaluation
8. Limited knowledge of the benefitsb
of transplantation
9. Inability to pay for out-of-pocket costs
associated with the evaluationa
10. Limited health literacyb
11. Distance to transplant from patient’s
housea
12. Limited information about the medical
evaluation processb
13. Religious beliefsa
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52
40
38
33
32

45.22
34.78
33.04
28.70
27.83

15
11
11
11
12

31
27

26.96
23.48

11
10

24

20.87

7

21

18.26

7

17
12

14.78
10.43

7
6

9

7.83

3

4

3.48

1

14. Racial discriminationc
15. Medical mistrusta
Other barriers
16. Lack of care partner supportc
17. Limited formal education
18. Limited/lack of social supporta
(especially lack of family support)
19. No localized testingc
20. No primary care physicianc
21. Poor comprehension of reading materialsb

3
2

2.61
1.74

1
2

*
*
*

*
*
*

Count
1
1
2

*
*
*

*
*
*

1
1
1

Note. N =23. The maximum possible priority score was 115. Priority scores were not calculated
for other barriers (not in the top 5) indicated by transplant professionals. aIndividual-level barrier,
b
Informational/educational barrier, cSystemic barrier and dHealth-related barrier.

Table 5
Patients’ Rankings of Barriers to Completing the Medical Evaluation
______________________________________________________________________________
Top Barriers
Total
Max Priority n of
Score
Score (%)
participants
ranking this
in their Top 5
1. Insurance issuesa
2. Scheduling difficulties (e.g., gettingc
an appointment for some tests takes a while)
3. Time constraints that make it difficult toa
complete several medical procedures/tests
4. Lack of a personal means of transportationa
5. Limited income/Low SES (including difficultya
covering the cost of medications)
5. Finding a living donora
6. Length of time to complete the medicalc
evaluation (e.g., time spent waiting for tests)
6. Medical complications (e.g., infections, health
problems)d
7. Poor communication with the transplant centerc
8. Length of time spend at the transplant center
(i.e., long appointment days)c
8. Limited/lack of social support (i.e., froma
family and friends)
8. Number of procedures and/tests required to
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32
19

24.62
14.62

9
5

19

14.62

4

16
11

12.31
8.46

4
3

11
9

8.46
6.92

3
2

9

6.92

2

8
7

6.15
5.38

2
2

7

5.38

2

7

5.38

2

complete the evaluationcd
9. Difficulties with the stress testc
7
5.38
2
10. Limited/lack of patient of motivationa
6
4.62
2
d
10. Multiple health conditions
6
4.62
2
11. Concerns about kidney rejection after
5
3.85
1
a
transplantation
11. Concerns about losing financial support after 5
3.85
1
transplantationa
11. Poor physician rapportc
5
3.85
1
11. Having to complete medical procedures/tests
5
3.85
1
c
at another facility
11. Limited/lack of family involvement in the
5
3.85
1
ac
evaluation process
11. Issues with medical compliancea
5
3.85
1
d
11. Medical readjustments
5
3.85
1
11. Multiple medical procedures/tests in one dayc 5
3.85
1
11. Not knowing whether the medical procedures/ 5
3.85
1
tests would disqualify patient from being
placed on the waitlista
11. Poor physical health (i.e. feeling sick)d
5
3.85
1
11. Smoking cessationa
5
3.85
1
c
11. Wait time for a deceased organ
5
3.85
1
11. Waiting for information about the
5
3.85
1
b
evaluation
12. Concerns about taking medicine for the
4
3.08
1
a
rest of the patient's life
12. Medical mistrusta
4
3.08
1
12. Navigating a large hospital (e.g. parking
4
3.08
1
c
difficulties, construction)
13. Fear of going to the dentista
3
2.31
1
13. Lack of communication between the dialysis
3
2.31
1
unit and transplant centerc
13. Length of time it takes for tests results to get to 3
2.31
1
the transplant centerc
14. Limited information about financial aspects of 1
0.77
1
the evaluationb
14. Difficulty maintaining social support
1
0.77
1
throughout process a
Note. N = 26, four participants did not provide rankings. The maximum possible priority score
was 130. Priority scores were not calculated for other barriers (not in the top 5) indicated by
patients. aIndividual-level barrier, bInformational/educational barrier, cSystemic barrier and
d

Health-related barrier.
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Rankings for Motivators to Completing the Medical Evaluation
To help address RQ2, thirteen motivators identified by transplant professionals were
ranked and assigned priority scores. The majority of the motivators prioritized were systemic in
nature (38.46%), four were informational/educational motivators (30.77%), two were individuallevel (15.38%), and the remainder were a combination of both individual-level and systemic
motivators (15.38%). The top five motivators were center-based education about the evaluation
process, instrumental support (e.g. help with childcare and transportation), patients’ knowledge
of the benefits of kidney transplantation over sustained dialysis, the availability of patient
navigators, and informational support about kidney transplantation (see Table 6).
To address R7, fifty-four motivators identified by patients were prioritized as facilitating
completion of the medical evaluation process. These motivators were classified into individuallevel motivators (38.89%), informational/educational motivators (25.93%), systemic motivators
(29.63%), and combinations of individual-level, systemic and informational/educational
motivators (5.55%). Patients ranked their top five motivators as social support, religious beliefs,
more information about the medical evaluation process, support from the transplant staff, and a
desire to get off dialysis (see Table 7).

Table 6
Transplant Professionals’ Rankings of Motivators to Completing the Medical Evaluation
______________________________________________________________________________
Top Motivators
Total
Max Priority n of
Score
Score (%)
participants
ranking this in
their Top 5
1. Center-based education about the evaluation
processb
2. Instrumental support (e.g. having assistance
with childcare and transportation) ac
3. Knowledge of the benefits of kidney
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59

53.64

18

56

50.91

17

49

44.55

14

transplantation over sustained dialysisb
4. Patient navigatorsc
5. Informational support (i.e. having people who
are knowledgeable of transplantation in one’s
social network)ac
6. Physician investmentc
7. Emotional support and counselingac
8. Comprehensive insurancec
9. Formal educationb
10. Exposure to diverse cliniciansc
11. Exposure to media promotion of thec
benefits of kidney transplantation
Other motivators
12. Ability to cover out-of-pocket costsa
13. Motivation to return to worka

46
40

41.82
36.36

15
15

25
19
19
11
5
1

22.73
17.27
17.27
10
4.55
0.91

9
8
7
4
2
1

*
*

Count
1
1

*
*

Note. N = 22, one participant did not provide motivator rankings. The maximum possible priority
score was 110. Priority scores were not calculated for other motivators (not in the top 5)
indicated by transplant professionals. aIndividual-level motivator, bInformational/educational
motivator, cSystemic motivator and dHealth-related motivator.

Table 7
Patients’ Rankings of Motivators to Completing the Medical Evaluation
______________________________________________________________________________
Top Motivators
Total
Max Priority n of
Score
Score (%)
participants
ranking this
in their Top 5
1. Social support (i.e., support from family
and friendsa
2. Religious beliefsa
3. More information on the evaluation
(e.g., what to expect, why it could take
about a year to complete) b
4. Support from transplant staff (e.g.,
doctors, coordinators, social workers) c
5. Desire to get off dialysisa
6. Knowing a successful transplant
recipientb
7. Good communication with transplant
staff (especially pre-transplant coordinators)bc
8. Follow up by transplant staff (including
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34

27.2

10

21
19

16.8
15.2

5
4

14

11.2

5

13
10

10.4
8

3
4

10

8

2

9

7.2

2

calls notifications/reminders for upcoming
appointments, what to expect, what's next)c
9. Motivation to return to worka
10. Knowing the medical procedures/tests
involved in the evaluation processb
11. Explaining information in manner that
facilitates understandingb
11. Financial assistance (e.g., to help with
the cost of medications)c
12. Decreasing the intervals between doctors'
appointmentsc
12. Desire to live because of family
(e.g. desire to live for children) a
12. Follow up appointments after medical
procedures/tests are completedc
12. Knowledge of transplantationb
12. Hearing stories from former kidney patientsa
12. Patient motivationa
12. Personal means of transportation without
relying on othersa
12. Providing reading information about kidney
transplantation for the patient to take homeb
12. Rehabilitation support for patients without
social support after transplantation c
12. Support from dialysis center c
13. Education about how to maintain contact
with pre-transplant coordinatorsb
13. Comprehension of the evaluation processa
13. Increased information sharing
(between patients)b
13. Kidney support groupsc
13. Knowing social workersa
13. Patient's desire to live longera
13. Support from primary care physicianc
14. Support from specialistsc
15. Communication between dialysis and
transplant centersc
15. Education about the benefits of
transplantationb
15. Improved scheduling of medical appointmentsc
15. Being able to ask questionsa
15. Continuous education as patients go through
the medical evaluation processb
15. Desire for better healtha
15. Knowing that kidney transplant is nearab
15. Meeting doctors and nursesa
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7
6

5.6
4.8

2
2

5

4

2

5

4

2

5

4

1

5

4

1

5

4

1

5
5
5
5

4
4
4
4

1
1
1
1

5

4

1

5

4

1

5
4

4
3.2

1
1

4
4

3.2
3.2

1
1

4
4
4
4
4
3

3.2
3.2
3.2
3.2
3.2
2.4

1
1
1
1
1
2

3

2.4

2

3
3
3

2.4
2.4
2.4

2
2
2

3
3
3

2.4
2.4
2.4

2
2
2

15. More Information about the transplant surgeryb
15. Physician repertoirec
15. Support from primary nephrologistc
15. Updates on position on the waitlistb
16. Desire to resume recreational activities
(e.g. travel) a
16. Improved access to social workers and
financial coordinators c
16. Information on how to raise funds to help with
financial costs associated with evaluationb
16. Patience (from patient) a
16. Seeing other peers (i.e. patients in the same
age group) in bad healtha
16. Support and information groupsbc
17. Change in patient’s perspective of diseasea
17. Focus group (from the current study)a
17. Patient navigatorsc
17. Occupational supporta

3
3
3
3
2

2.4
2.4
2.4
2.4
1.6

2
2
2
2
1

2

1.6

1

2

1.6

1

2
2

1.6
1.6

1
1

2
1
1
1
1

1.6
0.8
0.8
0.8
0.8

1
1
1
1
1

Other motivators
Count
17. Having a living donora
*
*
1
b
18. Knowledge of patient expectations
*
*
1
Note. N = 25, five participants did not provide motivator rankings. The maximum possible
priority score was 125. Priority scores were not calculated for other motivators (not in the top 5)
indicated by patients. aIndividual-level motivator, bInformational/educational motivator,
c
Systemic motivator and dHealth-related motivator.

Between-Group Differences and Similarities in Top Barriers in Rankings
Transplant professionals and patients similarly rated limited income/low SES, insurance
issues and lack of a personal means of transportation in their list of top five barriers. From the
perspective of transplant professionals, limited or lack of patient motivation and the number of
procedures and/or tests required during the pre-transplant evaluation are among the top five
barriers. Alternatively, patients listed scheduling difficulties and time constraints. Synonymous
rankings and differences between transplant professionals and patients in top five barriers are
depicted in Figure 3.
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Transplant
Professionals
Limited/lack
of patient
motivation
The number of
procedures and
/or tests required

BOTH
Limited income/
Low SES

Patients
Scheduling
difficulties

Insurance issues
Lack of a
personal means
of transportation

Time
constraints

Figure 3. Differences and Similarities between participant rankings of the top five barriers to
completing the medical evaluation process.

Between-Group Differences and Similarities in Top Motivators in Rankings
Transplant professionals listed center-based education, patients’ knowledge of the
benefits of transplantation over sustained dialysis and patient navigators as top motivators to
completing the evaluation process. In contrast, patients listed scheduling difficulties and time
constraints. Synonymous rankings and differences between transplant professionals and patients
in the top five motivators are depicted in Figure 4.
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Transplant
Professionals
Center-based
education
Patient’s knowledge
of the benefits of
transplantation over
sustained dialysis

BOTH
Informational
support (about
kidney
transplantation
and the medical
evaluation)
Social support

Patients
Religious beliefs

Desire to get off
dialysis
Support from the
transplant staff

Patient navigators

Figure 4. Differences and Similarities between participant rankings of the top five motivators to
completing the medical evaluation process.

Group Rankings of Top Five Barriers
Patients who participated in the focus groups included poor communication with the
transplant center and difficulty finding a living donor in their top five rankings. The top five
group rankings of barriers by focus group patients are displayed in Table 8.
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Table 8
Patient Group Rankings of Barriers to Completing the Medical Evaluation
______________________________________________________________________________
Top
Barriers
Total
Number of
Weighted
Score
Focus Groups/
Total (%)
n of participants
1. Insurance issues
2. Limited income/low SES
3. Poor communication with the
transplant center
4. Length of time to complete the
medical evaluation (e.g., for
appointments, for results)
5. Finding a living donor

20
12
9

6 (13)
3 (8)
2 (6)

36.36
21.82
16.36

8

3 (9)

14.55

6

2 (5)

10.91

Note. N = 22. Priority scores were calculated based on group consensus of the five top barriers
elicited during the NGT focus groups (i.e., 1st = 5 points, 2nd = 4 points, 3rd = 3 points etc.) and
expressed as a percentage of the weighted total of scores (55).
Group Rankings of Top Five Motivators
Focus group participants counted financial assistance throughout the evaluation process
and information about the medical evaluation process (e.g., financial and psychosocial
information). The top five group rankings of motivators are displayed in Table 9.

Table 9
Patient Group Rankings of Motivators to Completing the Medical Evaluation
______________________________________________________________________________
Top Motivators
Total
Number of
Weighted
Score
Focus groups/
Total (%)
n of participants
1. Social support
2. Information about the medical
evaluation process (including financial
and psychosocial-related information)
3. Religious Beliefs
4. Financial assistance throughout the
evaluation process
5. Support from dialysis center

18

5 (11)

32.14

10

2 (6)

17.86

10
9

2 (4)
3 (9)

17.86
16.07

9

2 (6)

16.07
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Note. N = 22. Priority scores were calculated based on group consensus of the five top motivators
elicited during the NGT focus groups (i.e., 1st = 5 points, 2nd = 4 points, 3rd = 3 points etc.) and
expressed as a percentage of the weighted total of scores (56).

Differences in focus group rankings of barriers based on patient status. To help
address RQ8, Status 1 and Status 7 patients’ group rankings were compared. Both Status 1 and 7
patients reported insurances issues in top five barriers. Status 1 patients also reported scheduling
difficulties, medical complications, multiple health conditions, and navigating a large hospital. In
contrast, Status 7 patients reported limited income/low SES, poor communication with the
transplant center, difficulties finding a living donor, and lack of social support.
Differences in focus group rankings of motivators based on patient status. To help
address RQ8, Status 1 and Status 7 patients’ group rankings were compared. Both Status 1 and 7
patients reported social support in top motivators. Status 1 patients also religious beliefs, support
from transplant staff, motivation to return to work and a personal means of transportation
without relying on relying on others. In contrast, Status 7 patients reported financial assistance
throughout the evaluation, information about the medical evaluation process, knowing a
successful recipient, and support from the dialysis center.
Summary of Barriers and Motivators and Possible Solutions
A summary of the top barriers, motivators and possible solutions to improve completion
rates of the medical evaluation project was developed in an attempt to combine the qualitative
and quantitative elements of this project. Table 10 provides a snapshot of the findings from both
transplant professionals and patients.
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Table 10
Summary of Top Barriers, Motivators and Possible Solutions
Top Barriers

Motivators/Possible Solutions
•
•

Insurance issues

•
•
•

Limited income/low SES

•
•
Lack of a personal means of transportation

•
•

Limited/lack of patient motivation

•

The number of procedures and/
tests required

•
•
•
•
•
•
•
•
•

Scheduling difficulties/Time constraints

•

Comprehensive Insurance
Information about financial aspects of the
evaluation (e.g., insurance paperwork)
Support from the transplant staff
especially financial coordinators
Financial assistance
Information on how to raise funds to help
with financial costs
Support from social workers and financial
coordinators
Family member assistance with costs of
completing the evaluation
Instrumental social support
Comprehensive insurance that includes
transportation
Creating programs to motivate or
empower patients
Kidney support groups
Hearing the stories of kidney recipients
Patient navigators
Informational support
Center-based education about the medical
evaluation process and kidney
transplantation
Education catered to patient’s
understanding
Centralized testing
Case management
Good communication between patients
and transplant center
Liaisons between transplant center and
dialysis center

Correlations
Transplant professionals’ ratings of perceived barriers and motivators indicated a number
of positive associations (see Table 11). This analysis was performed to determine whether certain
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barriers and motivators were related to each other. Based on Cohen’s (1998) interpretations, the
strength of these relationships ranged from moderate to large (r values ranged from .44 to .68).
For example, there was a positive relationship between income and knowledge of treatment
options, knowledge of the medical evaluation, health literacy and navigators, with strengths
ranging from moderate to large. Similarly, patient ratings of barriers and motivators revealed
several positive associations (moderate to large; r values ranged from .37 to .72) (see Table 11).
There was a positive relationship between income and distance to the center, comorbidities,
being on dialysis, health literacy and instrumental support. The strength of these relationships
were moderate to large.
Ratings for both transplant professionals’ and patients’ perceived barriers and motivators
to completing the medical evaluation process were also examined for associations (see Table 12).
There was a positive relationship between distance from the patient’s house to the transplant
center, and income, comorbidities, and instrumental support. The strength of these relationships
was large (r values ranged from .53 to.64). Knowledge of treatment options for kidney
transplantation was also positively related to knowledge of the medical evaluation process,
comorbidities, religious beliefs, and being on dialysis (r values ranged from .50 to .63).
Knowledge of the medical evaluation process was positively associated with health literacy,
comorbidities, navigators and having instrumental support (r values ranged from .52 to .63).
Furthermore, health literacy was positively related to medical mistrust, navigators, and having
instrumental support (r values ranged from .53 to .67). The two motivators, having navigators
and instrumental support, were also positively related (r =.67). Income level and being on
dialysis was also positively associated (r =.53). The majority of the other associations were
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moderately positive (r values ranged from .30 to .49) and the rest were small (r values ranged
from .28 to .29) (see Table 12).
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Table 11
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for Transplant Professionals
____________________________________________________________________________________________________________
1
2
3
4
5
6
7
8
9
10
11
12
1. Insurance status
2. Income
3. Distance to center
4. Comorbidities
5. Religious beliefs
6. Knowledge of treatments
7. Knowledge of evaluation
8. Dialysis
9. Health literacy
10. Medical mistrust
11. Navigators
12. Instrumental support

-

.68**
-

.06
.41
-

-.20
.16
.46*
-

**p < .01; *p < .05.
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.04
-.05
.18
.20
-

.41
.48*
.11
.27
.39
-

.20
.53**
.25
.28
.07
.56**
-

.29
.30
.12
-.001
-.01
.15
.17
-

.36
.44**
.27
.20
.24
.47*
.35
.50*
-

-.02
.02
.03
-.04
.46*
.26
-.07
.33
.47*
-

.34
.58**
.13
.19
.07
.53**
.29
.50*
.35
.23
-

.42*
.30
.10
.32
-.10
.33
.24
.06
.47*
-.08
.21
-

Table 12
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for Patients
____________________________________________________________________________________________________________
1
2
3
4
5
6
7
8
9
10
11
12
1. Insurance status
2. Income
3. Distance to center
4. Comorbidities
5. Religious beliefs
6. Knowledge of treatments
7. Knowledge of evaluation
8. Dialysis
9. Health literacy
10. Medical mistrust
11. Navigators
12. Instrumental support

-

.45*
-

.47**
.46**
-

.42*
.42*
.55**
-

**p < .01; *p < . 05.
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.16
.34
.17
.28
-

.34
.31
.34
.43*
.46*
-

.29
.24
.26
.45*
.37*
.54**
-

.26
.54**
.32
.48**
.31
.63**
.32
-

.21
.46*
.39*
.36
.12
.11
.51**
.19
-

-.08
.23
.02
.12
.22
-.03
-.04
.19
.52**
-

.32
.13
.45*
.35
.11
.39*
.52**
.25
.65**
.43*
-

.40*
.42*
.47**
.34
.29
.25
.60**
.21
.68**
.32
.72**
-

Table 13
Pearson’s Product Moment Correlations for Perceived Barriers and Motivators for all participants
____________________________________________________________________________________________________________
1
2
3
4
5
6
7
8
9
10
11
12
1. Insurance status
2. Income
3. Distance to center
4. Comorbidities
5. Religious beliefs
6. Knowledge of treatments
7. Knowledge of evaluation
8. Dialysis
9. Health literacy
10. Medical mistrust
11. Navigators
12. Instrumental support

-

.46**
-

.23
.53**
-

.16
.45**
.64**
-

**p < .01; *p < . 05.
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.09
.29*
.28*
.34*
-

.26
.45**
.47**
.53**
.50**
-

.20
.40**
.42**
.53**
.37**
.63**
-

.20
.53**
.42**
.45**
.28*
.58**
.40**
-

.21
.49**
.42**
.39**
.20
.26
.53**
.33*
-

-.08
.24
.23
.12
.33*
.15
.07
.31*
.53**
-

.28*
.30*
.45**
.38**
.16
.48**
.52**
.38**
.62**
.42**
-

.30*
.47**
.54**
.47**
.29*
.42**
.63**
.32*
.67**
.33*
.67**
-

Test of Between Group Differences
To help address RQ9, Mann-Whitney U tests were conducted to examine differences
between transplant professionals and patients in perception of barriers to completing the medical
evaluation process. Transplant professionals (Md =48, n =23) reported significantly more
perceived barriers than patients (Md =34.5, n =30), U = 133.50, z = -3.78, p= <.001, r = .52 (a
large effect). Two Mann-Whitney U tests were used to examine participant (i.e. transplant
professionals and patients) differences in perceived motivators. Specifically, navigators and
instrumental support served as a positive impact on completing the medical evaluation process.
The was no significant difference between transplant professionals’ (Md =6, n =23) and patients’
(Md =4.50, n =30), U = 281.50, z = -1.16, p= .25, perceptions of navigators as a positive impact
on completing the medical evaluation process. In contrast, there was a significant difference
between providers’ and patients’ perceptions of instrumental support as a positive impact on
completing the medical evaluation process, U = 207, z = -2.56, p= .01. Specifically, transplant
professionals (Md =6, n =23) reported instrumental support as having a greater positive impact
on completing the medical evaluation process than did patients (Md =5, n =30).
Discussion
Renal patients experience a myriad of barriers throughout the medical evaluation process.
The multitude of barriers can overwhelm attempts to finding solutions for overcoming these
barriers. Categorizing and prioritizing factors that impact completion of the medical evaluation
process is essential to helping African American patients proceed through the evaluation process
and be listed for transplantation. The present study sought to determine the most important

76

factors that facilitate and/or impede progression through the medical evaluation by examining the
perceptions of both transplant professionals and patients.
Thematic analyses of both semi-structured interviews with transplant professionals and
focus groups with patients revealed that renal patients going through the medical evaluation
process are most impacted by barriers at the individual-level. Many of these barriers are socioeconomic (e.g., insurance issues, limited income, transportation difficulties and lack of social
support). This finding corresponds with past literature which indicates that poor Black patients
experience longer commutes to the transplant center, have less access to transportation, and those
without good health insurance coverage are more likely to face barriers in attempts to seek
kidney transplantation (Axelrod et al., 2010; Clark et al., 2008; Patzer et al., 2012). Concerns
about finding a living donor and the costs associated with the evaluation were also reported to
impact patients’ completion of the medical evaluation process. A recent study by Dageforde and
colleagues (2015) reported synonymous findings as patients indicated concerns about their
ability to find a living donor, and the costs of medications. Further, patients who reported
transportation difficulties were less likely to complete their evaluation. Other types of individuallevel factors identified were lack of patient motivation, fears about losing disability benefits after
transplantation, fears about the transplant surgery, religious beliefs and medical mistrust. Past
research has also suggested that medical mistrust may be a contributing factor to the disparity
between African Americans and other racial groups in access to kidney transplantation (Churak,
2005; Moore, 2007).
Transplant professionals and patients differed in the number of informational/educational
barriers versus systemic barriers cited as impacting completion of the medical evaluation
process. The next category of barriers most reported by transplant professionals were
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informational/educational barriers. They identified barriers such as lack of knowledge about
kidney transplantation, and more specifically lack of knowledge of the medical evaluation
process as well as limited formation education. One explanation for patients’ limited knowledge
of transplantation is that some patients first hear about transplantation from their doctors and
nurses (Weng et al., 2005), particularly during their initial appointment for the pre-transplant
workup. Patients’ lack of information about transplantation is well documented (Alexander &
Sehgal, 1999; Navaneethan & Singh, 2006; Weng et al., 2005), even though dialysis centers are
required to educate patients about transplantation annually (CMS, 2008). Gaps in formal
education were also found to contribute to barriers in completing the medical evaluation in a
study that compared Black and Whites referred for a pre-transplant workup (Patzer et al., 2012).
Patients named systemic barriers as second in the likelihood to impact completion of the
medical evaluation process. Specifically, they mentioned poor communication between the
patients and transplant staff, scheduling difficulties, having to work with several doctors, long
wait times for doctors’ appointments and test results, and not having access to the transplant
coordinators as well as difficulties navigating the hospital system. Of note, the PI observed a
disparity between some patients’ report of their activation status on the transplant list and what
the transplant center indicated as their activation status – these patients believed they had
completed their evaluation even though they had been listed as inactive, lending some support to
patients’ report of poor communication with the transplant center. While it is possible that the
status of some of the patients may have changed between the time in which the PI obtained the
list of potential participants and actual participation in the study, other research confirms this
finding (Gillespie, Hammer, Lee, Nnewihe, Gordon & Silva, 2011). Gillespie and colleagues
revealed in a survey of hemodialysis patients undergoing the pre-transplant work-up that the
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majority of these patients erroneously perceived themselves to be active on the waitlist whereas
over half lacked knowledge of their status (Gillespie et al., 2011).
Transplant professionals and patients also differed with regard to the third type of barrier
to completing the medical evaluation process. Nephrologists, transplant coordinators, social
workers, psychologists and a transplant nurse ranked systemic barriers as third, whereas patients
reported health-related barriers as having the third most impact on progress to transplant
candidacy. Similar to previous studies, delayed referral processes were cited by transplant
professionals as contributing to this barrier (Alexander & Sehgal, 1999; Joshi et al., 2012).
Health-related barriers reported by patients included health status (e.g., feeling physically sick or
fatigued), not being cleared by psychiatry, and having multiple health conditions that required
treatment prior to activation on the transplant waitlist. Comorbidities that increase the number of
medical procedures required for clearance have been known to limit renal patients’ progression
through the medical evaluation (Danovitch et al., 2004; Navaneethn & Singh, 2006).
The fourth type of barrier identified by transplant professionals were health-related
barriers. In contrast, patient identified informational/educational barriers. Patients expressed a
need for information about the medical evaluation process, especially the number of tests
involved and the financial aspects of getting a transplant. Notably, transplant professionals
reported more barriers relative to patients. This could be attributed to the fact that transplant
professionals have a broader view of some of the problems faced by patients given that they
consult with several patients. However, in comparison to the majority of patients who have
participated in the medical evaluation, the sample surveyed for the current study may have
experienced fewer barriers. For example, the majority of the study participants lived within a
twelve-mile radius of the transplant center and had access to transportation.
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Motivators were also categorized, with transplant professionals’ identifying systemic
motivators most frequently, followed by informational/educational motivators and individuallevel motivators. Specifically, transplant professionals indicated systemic motivators such as
more referrals from local nephrologists, patient navigators, case management, physician rapport,
compressed testing and comprehensive insurance. Informational/educational motivators
consisted of center-based education, formal education, presenting information in lay terms, and
education about transplantation to help improve completion rates. Individual-level motivators
included patients’ desire to get off dialysis or have a better quality of life, religious beliefs that
motivate patients, and knowledge of a successful recipient. Alternatively, patients identified
individual-level motivators most frequently followed by systemic and informational/educational
motivators. Individual-level motivators consisted of family support, financial support from
family members, support from the transplant staff, and religious beliefs. Systemic motivators
were good communication with the transplant coordinators, updates on the patient’s position on
the transplant waitlist, and rehabilitation support for patients without family support.
Informational and educational motivators included transplant education, having the transplant
information geared to the patient’s understanding and knowledge of successful transplant
recipients. Many of the motivators reported by patients and transplant professionals aligned with
the extant literature. Specifically, social networks (especially instrumental support), previous
knowledge of transplantation, information about the benefits of transplantation, comprehensive
insurance, support from transplant staff and patient navigators have a positive impact on patients’
completion of the medical evaluation process (Clark et al., 2008; Dageforde et al., 2015; Sullivan
et al., 2012; Weng et al., 2005). A surprising finding was that for the majority of patients in this
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study, religious beliefs actually encouraged completion of the evaluation rather than imposing a
barrier.
Given the multitude of factors contributing to completion of the transplant medical
evaluation, prioritization is critical to understanding the most important and potentially
modifiable factors and identifying solutions for their remediation. Participant rankings of the top
five barriers and motivators to completing the medical evaluation served this purpose. Patient
and transplant professional similarly ranked insurances issues, low SES/limited income and lack
of a personal means of transportation in their top five barriers to completing the medical
evaluation process. Transplant professionals also ranked lack of patient motivation and the
number of tests or medical procedures required to finish the medical evaluation process in their
top five. Patients ranked scheduling difficulties and time constraints in trying to attend their
medical appointments, dialysis, and participate in regular activities in their top five. The latter
barriers are related to the number of tests required to complete the evaluation process since
patients have to undergo several medical procedures to become active on the waitlist. Although,
transplant professionals may perceive some patients as lacking in motivation, this could be
attributed to a number of factors. For example, patient fears about losing their benefits after
transplantation or fear of the transplant operation may lead to reduced motivation. Further, many
renal patients are physically ill due to prolonged dialysis therapy or as a result of having several
comorbidities. Hence, attending several medical appointments is bound to create additional
strain, making patients appear less motivated. Transplant professionals may also fail to
acknowledge the informational/educational and systemic barriers patients face which results in
the perception of patients as lacking motivation.
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Participants’ rankings of motivators were also prioritized with both transplant
professionals and patients prioritizing social support and informational support. Transplant
professionals ranked center-based education, patient’s knowledge of the benefits of
transplantation over dialysis and patient navigators in their top five. In contrast, patients ranked a
desire of get off dialysis, religious beliefs and support from the transplant staff in their top five.
Together, improvements in transplant education, and additional services and support from the
transplant center facilitate patient’s completion of the medical evaluation. Additional solutions to
reducing the barriers faced by African American renal patients proposed by transplant
professionals and patients include comprehensive insurance, financial assistance, assistance with
fundraising, creating programs to motivate and empower patients, and continuous education
throughout the medical evaluation process. Also, hearing the success stories of kidney recipients,
kidney support groups, patient navigators, case management, good communication between the
transplant staff and patients, and liaisons between the transplant center and dialysis center were
suggested as solutions.
This current study is the first to demonstrate the value of categorizing and prioritized the
multitude of factors that impact completion of the medical evaluation process. The use of a focus
group with a NGT to prioritize these factors was both innovative and pertinent to determining
what is most beneficial for helping these population complete the pre-transplant work-up.
Moreover, categorizing these barriers and motivators has the added value of improving
researchers and providers’ understanding of their patients’ needs and will help target
interventions. For example, improving center-based education for patients whose barriers are
mostly health-related would likely have minimal benefit for improving their odds of completing
the medical evaluation process. The current study indicates that African American patients are
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faced with several barriers, many of which are the result of socioeconomic disadvantages.
Categorizing barriers and motivators to completing the medical evaluation process is the first
step in tackling the disparity in access to transplantation between African Americans and other
racial groups. Additional resources such as financial assistance, fundraising, comprehensive
insurance plans that include assistance with transportation, encouraging family engagement for
instance, would likely enhance African American renal patients’ ability to complete the medical
evaluation process. This study proposed a structure for categorizing factors that impact
completion of the medical evaluation process by dividing barriers and motivators into individuallevel, systemic, informational/educational and health-related barriers and motivators. Creating a
system that categorizes barriers and motivators to pre-transplant work-up completion better
equips transplant centers for honing in on ways to help their African American patients complete
their evaluation. The prioritization of the top barriers and motivators is also valuable for
prioritizing patient needs.
Strengths, Limitations and Future Studies
There are several strengths to the current study. This study provides a better
understanding of the experience of African American renal patients. Although previous literature
has identified several barriers and motivators to completing the medical evaluation process, no
study to date has employed the nominal group technique to categorize and prioritize these
factors. The current study provides a structure to help understand these factors in order to find
solutions that will ultimately bring parity in access to kidney transplantation for African
American patients. By gathering information from both transplant professionals and patients, this
study provides the additional advantage of a broader understanding of the pre-transplant work
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up. Furthermore, the use of a mixed methods approach provides a thorough form of analysis
which extends the previous literature.
There are a number of limitations to this study. Given that snowballing was used as the
main recruitment tool with the transplant professional sample, this may limit findings as those
who agreed to participate may be motivated by a desire to know more about this topic.
Additionally, with snowballing, information sharing may be restricted to in-group members
reducing the diversification of participant responses. Future studies should implement an
assortment of recruiting techniques to facilitate the generation of a variety of participant
responses. Patients who participated in the study had to come to the study location. This is
another limitation to the study given that one of the top five barriers to completing the medical
evaluation is access to transportation. Therefore, the study sample may be biased since those who
participated may actually have fewer barriers in comparison to the larger population of African
American renal patients. Nonetheless, these participants were still able to list a substantial
number of barriers, highlighting the magnitude of difficulties faced by all renal patients. Future
studies should be conducted with a heterogeneous group of patients. A community-based
research study in which the researchers conduct the study at a convenient location for patients
would preferable. For example, at the transplant center during patients’ appointment, at a dialysis
center or by making house calls. Another limitation is that participants who were more reserved
in the focus groups may have felt limited in their ability to voice their opinions during the
discussions, possibly limiting the emergence of alternative responses.
Given that this study was able to generate a structure for categorizing patient barriers and
motivators, future studies should develop a psychometrically-sound questionnaire that measures
these barriers and motivators. Consequently, this could be used for additional exploration of this
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phenomenon as well as used in transplant centers to assess possible barriers to completion of the
medical evaluation process, and identify services needed to enhance patients’ ability to progress
through the evaluation process to transplant candidacy. Such a tool would better equip transplant
professionals to help patients overcome barriers to completion of the pre-transplant work up.
Conclusion
The findings from the current study are useful for providing vital information to
transplant centers nationally as it could help improve centers’ ability to meet the needs of all
patients seeking transplantation, especially African American patients. In consulting with renal
patients, it is recommended that transplant professionals attempt to assess barriers and
motivators. For example, one participant indicated that her local nephrologist ordered some of
the tests she needed for the medical evaluation prior to her initial appointment. As a result, the
patient had completed many of the medical procedures before her appointment, making it easier
to complete her evaluation. This is an example of simple process that can become standard
procedure for the medical evaluation for kidney transplantation.
These results from the current study could also inform intervention programs targeting
African American renal patients’ ability to completion of the medical evaluation. For example,
an intervention with kidney support groups could be implemented to determine its utility for
helping improve completion rates. Given that religious beliefs were revealed as a facilitator of
completion of the medical evaluation process, involving churches, faith communities and
community organizations has the potential for boosting completion rates.
The results of the current study also suggest that a change in the policy of patients losing
their benefits, three years post-transplant is warranted. This policy creates an additional burden
for renal patients, many of whom may have been out of the workforce for several years due to
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their condition. Although they may be ready to join the workforce three years post-transplant, it
may be an unrealistic expectation for all patients as a prolonged departure from the workforce
may reduce job prospects and leave patients struggling to find work that pays enough to cover
the cost of medications. Comprehensive insurance plans are also critical for renal patients given
that some patients may be unable to afford co-pays, especially when they are required to undergo
several medical procedures and may have to attend specialist appointments. Out-of-pocket costs
associated with transplant such as paying for lodging to attend doctors’ appointments and
transportation difficulties create an additional burden for patients. Currently, ESRD patients
qualify for Medicare part A (Hospital insurance) and can also obtain part B (Medical insurance)
which has a monthly premium. Both of these services facilitate a patient’s ability to obtain full
benefits to cover the cost of certain renal replacement therapies (CMS, 2016). Specific to
transportation, these services only cover ambulance services and do not cover doctor’s visits or
trips to the dialysis center. Patients with a Medicare part C (Medicare Advantage Plan) and
those with Medicaid are the only ones eligible for coverage of non-emergency doctors’ visits. It
may be beneficial to extend transportation services to all ESRD patients to reduce the
transportation barriers faced by these patients. Further, patients should be supplied with
information about national organizations such as the American Kidney Fund and fundraising
tools when they initiate the medical evaluation process to expand their access to resources that
can help reduce their financial barriers.
In November 2013, the OPTN policy changed to allow patients with an inactive status to
accrue time on the waitlist. It is unknown whether this change in policy will impact African
American renal patients’ completion of the medical evaluation. Nonetheless, the information
gathered from the current study could help inform systemic changes that would in turn narrow
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the health disparities in access to kidney transplantation between African Americans and other
racial groups.
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Appendix A
Transplant Professionals’ Interview Protocol
Opening Script:
Thank you for taking the time to speak with me today about your perceptions of the factors
impacting the completion of the medical evaluation for renal patients seeking kidney
transplantation. My name is Camilla Nonterah and I am a VCU counseling psychology doctoral
candidate working on my dissertation research. The purpose of this interview is to gather
transplant professionals’ perceptions of the factors that facilitate and impede renal patients’
completion of the medical evaluation process for kidney transplantation. Please know that your
opinions are appreciated and your honesty and experience working with renal patients is valued.
The results of the interviews will be incorporated into the second part of my study which will
examine the views of patients to have a better understanding of the medical evaluation process
for this population. With your permission I would like to record this interview, your identity and
what you say will be kept confidential. Your name will not appear in the interview transcript or
any summary reports. The interview will last about 45-60 minutes. Do you have any questions
before we begin?
Experience:
1. Please describe your experience working with ESRD patients seeking a transplant? [Probe:
How long have you worked with this population? Overall, would you say that your experience
with has been generally positive or negative? Why? What challenges have you faced in working
with patients seeking kidney transplantation?]
2. How has your experience differed when working with patients of different sexes (male versus
female)? [Probe: That is, in what ways is it easier or more difficult to work with males as
compared to females?]
3. How has your experience differed when working with patients from different racial and/or
ethnic backgrounds (for example, African American patients versus Caucasian patients)?
[Probe: That is, in what ways is it easier or more difficult to work with African Americans as
compared to Whites?]
Medical Evaluation Process:
4. Please describe the medical evaluation process at your transplant center? [Probe: What tests
and/or medical procedures must patients undergo to be evaluated and listed for
transplantation?]
5. How long does it take the average patient to complete the evaluation process? [Probe: And,
how long does it typically take for patients with multiple other health issues, in addition to renal
failure, to complete the medical work up?]
6. At what point in the evaluation are patients most likely to stop completing or drop out of the
process?
7. What challenges do patients at your center face in completing the medical evaluation for
listing for kidney transplantation? [Probe: For example, perhaps insurance issues, the sheer
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number of tests, or transportation difficulties interfere with patients’ ability to complete the
evaluation? Anything else?]
As you may already know, ethnic/racial disparities have been found in all aspects of
transplantation, including patients’ completion of the medical evaluation process and
subsequent listing for transplantation. While I’m interested in finding ways to improve the
process and reduce barriers to completing the transplant evaluations for all patients, I’m
particularly interested in reducing or eliminating these disparities. So, for the following
questions, I will ask about potential barriers to completing the process that all patients may
face; then, I will ask you to think specifically about barriers for Blacks/African American
patients.
Barriers:
8. What individual-level factors impede patients’ completion of the evaluation process? [Probe:
In your experience, have religious beliefs, medical mistrust, motivation, or some other factors
kept patients from completing the process? NB: Write down individual-level factors mentioned
by participant]
9. What health-related factors keep patients from finishing the evaluation process? [Probe: In
your experience, have the number or nature of any additional health issues prevented or
impeded patients’ completion of the medical evaluation? NB: Write down health-related-level
factors mentioned by participant]
10. What system-level factors keep patients from finishing the evaluation process and being
listed for transplantation? [Probe: That is, what problems in the healthcare system, such as the
evaluation process itself or the lack of patient navigators, affect patients’ ability to complete the
testing process? NB: Write down system-level factors mentioned by participant]

11. What information or education-related factors keep patients from finishing the process?
[Probe: In your experience, have patients’ limited knowledge of transplantation or the medical
evaluation process impacted their completion of the evaluation? NB: Write down information
or education-related factors mentioned by participant]

So, we’ve now discussed a variety of potential barriers to patients’ successful completion of the
medical evaluation and subsequent wait listing for kidney transplantation.
12a. How do you think these barriers differ depending on the patient’s gender? [Probe: What
factors, if any, are specific to women or specific to men (that is, they do not impede men but do
limit women’s capacity to compete the evaluation or vice-versa)?]

12b. How might these factors affect African American and Caucasian patients differently?
[Probe: What factors, if any, are specific to African American patients (that is, they do not
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impede Caucasian patients but do limit African Americans’ capacity to compete the evaluation)?
NB: Remind participant of individual, health, systemic, information list above if needed]

The following questions focus solely on your experience working with Black/African
American patients. Please answer Yes or No to each question.
13a. In your experience, have Black patients’ income level impacted their ability to complete the
medical evaluation process? [Probe for transportation difficulties, ability to pay for food or
lodging]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
13b. If yes, how?
13c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (income level)?
14a. Do you believe that the distance from the transplant center to a patient’s house impacts
Black patients’ ability to complete the evaluation? [Probe for difficulties coming to appointments
or finding lodging]
0

□ No

1
2

□ Yes
□ Depends

14b. If yes, in what way or ways?
If no skip to next question
14c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (distance from the transplant center to a patient’s house)?
15a. Health literacy is defined as the degree to which individuals have the ability to obtain,
process and understand basic health information and services in order to make appropriate
health decisions. Do you think that health literacy has an impact on African American patients’
ability to complete the medical evaluation process?
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
15b. If yes, how?
15c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (health literacy)?
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16a. Does knowledge about the different treatment options available impact Black patients’
ability to complete the medical evaluation process? [Probe for lack of knowledge about the
benefits of kidney transplantation]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
16b. If yes, how?
16c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (knowledge about the different treatment options available)?

17a. Does knowledge about the medical evaluation process, including the time it will take to
complete all the necessary tests and the specific tests that will be conducted, impact African
American patients’ ability to complete the process? [Probe for a lack of understanding of the
process]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
17b. If yes, how?
17c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (knowledge about the medical evaluation process)?
18a. Do comorbidities (i.e., other illnesses in addition to ESRD) impact Black patients’ ability to
complete the evaluation? [Probe for an increase in the number of tests they need to complete]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
18b. If yes, how?
18c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (comorbidities)?
19a. In your experience, have religious beliefs impacted African American patients’ ability to
complete the medical evaluation process? [Probe for beliefs regarding personal sacrifice,
carrying personal burdens alone, or concerns about desecrating the body through
transplantation]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
19b. If yes, how?
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19c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (religious beliefs)?

20a. Medical mistrust is defined as concerns about trust and discrimination in populations of
patients with chronic illness. Do you believe that medical mistrust impacts Black patients’ ability
to complete the process? [Probe for discrimination or perceived prejudice by health care
providers]
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
20b. If yes, how?
20c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (medical mistrust)?

21a. Navigators are individuals who educate patients and help them navigate through the
medical system. Does the lack of patient navigators impact African American patients’ ability to
complete the process?
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
21b. If yes, how?
21c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (navigators)?

22a. Instrumental support networks are defined as the number of close friends or family that can
help with daily activities at home. This means does the patient have people who help him/her
with activities such as cooking, child care, scheduling appointments and transportation?
Does instrumental support, or the lack thereof, impact African American patients’ ability to
complete the medical evaluation process?
0 □ No
1 □ Yes
2 □ Depends
If no skip to next question
22b. If yes, how?
21c. Are Blacks/African American patients more or less likely than White/Caucasian patients to
be affected by this (instrumental support networks)?
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Motivators:
23. What factors motivate patients to complete the evaluation process? [Probe: What individual,
systemic, health or information related factors motivate patients to complete the evaluation
process?

24. Please complete this statement. In my experience, the typical patient who completes the
medical evaluation process is ………. [Probe: Those who complete the medical evaluation are
typically of what gender, racial group, age etc?]
Potential Solutions:
25. In your opinion, what might be done to help patients overcome these barriers and complete
the medical evaluation process?

26. What would you recommend to help African American patients, specifically, complete the
medical evaluation process and reduce disparities in this aspect of transplantation?
Finally, as part of this project, I will compare transplant professionals’ rankings of the barriers
and motivators to patients’ completion of the medical evaluation process to patients’ rankings.
Please take a moment now to numerically rank the 5 most significant barriers and motivators
from the following lists [from the list emailed to you at the start of this interview].
Closing Script:
Thank you for your time today. Here is a $5 Starbuck’s gift card as thanks for your time and
participation. If you have any additional comments or questions about this research, please
contact me, Camilla Nonterah, at nonterahcw@vcu.edu.
Would you like a copy of the results when they are ready?
0 □ Does not want results
1

□ Wants results
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Appendix B
TRANSPLANT PROFESSIONALS SURVEY
1. What is your race?
1
□
2
□
3
□
4
□
5
□
6
□
8
□

African American
Asian/Pacific Islander
Caucasian
American Indian/Alaskan
Mixed race (Specify:__________________________)
Other (Specify:______________________________)
NR/NA

2. Respondent’s gender:
1 □ Male
1 □
3. Occupation
1 □
2 □
3 □
4 □

Female
Nephrologist
Transplant coordinator
Social Worker
Other (Specify:______________________________)

4. What is the highest grade or degree you have completed? _____________ (Grade/Degree)
1
□
High school or less
2
□
Associate’s degree
3
□
Some college, no degree
4
□
More than Associate’s degree, but no Bachelor’s degree
5
□
Bachelor’s degree
6
□
Some graduate school, no degree
7
□
Master’s degree
8
□
Uncompleted graduate training beyond a Master’s degree
9
□
Doctorate
88
□
NR/NA
5. Years of experience working with transplant patients ________________?
Please tell me how much you think the following impact the medical evaluation process
6. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think an African American patient’s health insurance
status impacts their ability to complete the medical evaluation process?
1

2

3

4

5

Not at
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6
all

7
Strongly impacts

7. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5
and 6 in between, how much do you think an African American patient’s income level impacts
their ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

8. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5
and 6 in between, how much do you think the distance from the transplant center to the patient’s
house impacts an African American patient’s ability to complete the medical evaluation process?
1

2

3

4

5

6
7
Not at
all
Strongly impacts
9. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4, 5
and 6 in between, how much do you think comorbidities (i.e. a patient having other illness in
addition to ESRD) impact an African American patient’s ability to complete the medical
evaluation process?
1

2

3

4

5

1

2

3

4

5

6
7
Not at
all
Strongly impacts
10. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think an African American patient’s religious beliefs
impacts their ability to complete the medical evaluation process?

Not at

6
all

7
Strongly impacts

11. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think an African American patient’s knowledge about
different treatments impacts their ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

12. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, , how much do you think an African American patient’s knowledge about
the medical evaluation process impacts their ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

13. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, , how much does being on dialysis impact an African American patient’s
ability to complete the medical evaluation process?
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1

2

3

4

5

Not at

6
all

7
Strongly impacts

14. Health literacy is defined as the degree to which individuals have the ability to obtain,
process and understand basic health information and services in order to make appropriate
health decisions. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly
impacts” with 2, 3, 4, 5 and 6 in between, how much do you think health literacy impacts an
African American patient’s ability to complete the medical evaluation process?
1

2

3

4

5

6
7
Not at
all
Strongly impacts
15. Medical mistrust is defined as concerns about trust and discrimination in populations of
patients with chronic illness. On a scale from 1 to 7, with 1 being “Not at all” and 7 being
“Strongly impacts” with 2, 3, 4, 5 and 6 in between, how much do you think medical mistrust
impacts an African American patient’s ability to complete the medical evaluation process?
1

2

3

4

5

6
7
Not at
all
Strongly impacts
16. Navigators are individuals who educate patients and help them navigate through the medical
system. On a scale from 1 to 7, with 1 being “No impact” and 7 being “Extremely positive
impact” with 2, 3, 4, 5 and 6 in between, how much would navigators impact an African
American patient’s ability to complete the medical evaluation process?
1
2
3
4
5
6
7
No at
all
Extremely positive impact
17. Instrumental support networks are defined as the number of close friends or family that can
help with daily activities at home. On a scale from 1 to 7, with 1 being “No impact” and 7 being
“Extremely positive impact” with 2, 3, 4, 5 and 6 in between, how much would instrument
support impact an African American patient’s ability to complete the medical evaluation
process?
1

2

3

4

5

Not at

109

6
all

7
Extremely positive impacts

Appendix C
ESRD Patients Nominal Focus group (Status 1 &2) Protocol
I. Introduction
Thank you all for coming today/tonight. My name is Camilla Nonterah and I am a counseling
psychology doctoral student at VCU. Assisting me today is __________. Thank you for agreeing
to participate in this study. The information you provide will be very useful in helping us
understand the factors which impact the completion of the medical evaluation process for end
stage renal disease (ESRD) patients.
II. Description of Focus Group:
To begin, I would like to give you an overview of how this focus group will work. As you know,
the focus group will last for about 45 minutes to 1 hour. During this time period, I will ask you
some questions about your experience as a patient with end stage renal disease (ESRD). While I
encourage you to draw on your experience, we do not need to know the details of your medical
history or specific visits. The goal is for you to discuss the questions as a group. The most
important information will come from the range of everyone’s thoughts and ideas. It is very
important that everyone speaks their mind and participates, particularly if you have a different
perspective from others in the group. There are no “right” or “wrong” answers to the questions.
We are interested in the full range of perspectives.
My role is to help facilitate the discussion of this topic. I may ask specific individuals about their
thoughts or ideas if they have not had a chance to participate very much in the discussion. I also
may have to interrupt someone to ask that we get everyone’s opinion or to move on to another
topic. This is to ensure that we get everyone’s views on all the questions in the relatively short
time we have together.
Another important ground rule for this meeting is that we will respect the privacy of all group
members and keep the content of our discussion confidential. We will call each other only by
first names, and your verbal and written comments will be kept strictly confidential. I will be
audiotaping the discussion, and you may see me taking notes. These steps are necessary for us to
accurately record what is said today/tonight, but we will not include any information that will
personally identify you in our notes or recordings. At any point in time, you are free to stop
participating in the discussion or even leave. When we analyze our notes from this discussion,
we will be most interested in what the group as a whole has to say. After we complete the
analysis, we will erase and throw away the tape recording. When we publish the results of our
study, no individuals will be identified. Finally, please remember that located on your consent
form are the names and numbers of people you can call in future if you have questions about
your rights as a research participant.
Does anyone have any questions? [Answer any questions]
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III. Warm up [7 minutes]
Before moving on to the main topic of our discussion, I would like to take a few moments for
everyone to introduce himself/herself. Specifically, I would like everyone to tell us their first
name (you can also choose a pseudonym) and briefly tell us what their hobbies or interests are.
Let me begin….
[Moderator: Introduces herself/himself and then goes around the table.]
[Moderators Assistant: Will take notes on where particular people are sitting by creating a
diagram similar to the room and focus group layout. Individual first names will then be
associated with a numbered position in the diagram. These numbers make it possible to follow
more accurately who in the group is speaking when listening to the tapes again as well as
confidentially matching forms completed during the focus group with names.]
______________________________________________________________________________
TOPIC 1: INTRODUCTION
1. What made you interested in participating in this study? [Probe: Are you interested in the
topic? Are you looking for answers? Are you hoping that your participation will help
others?]
TOPIC 2: ESRD EXPERIENCE
2. Describe your experience so far as a patient with kidney disease? [Probe: What
challenges have you faced as a patient with ESRD?]
TOPIC 3: MEDICAL EVALUATION EXPERIENCE
3. What information have you been given about the medical evaluation process? [Probe:
Were you provided with information about the evaluation process itself and the number
of tests you would have to take for instance? Were you given with information about the
risks and benefits of kidney transplantation? Were you given information about what will
happen after transplantation?]
What information would have been helpful? [Probe: Would you have liked additional
information about the evaluation process such as the number of tests you have to take,
possible insurance issues, the importance of having others who could support you
through the process?]
4. Where are you in the medical evaluation process? [Probe: Have you completed the
process and all necessary requirements?]
5. What tests did you have to complete? [Probe: That is have you finished the basic blood
work and initial testing? What tests are you yet to complete?]
6. What was it like for you to go through the medical evaluation process? [Probe: Overall,
would you say that your experience with has been generally positive or negative? Why?
Are there certain things which have been particularly difficult?]
TOPIC 4: MOTIVATORS TO COMPLETING THE MEDICAL EVALUATION
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7. What are some things which made it easier to complete the medical evaluation process
for kidney transplantation? [Probe: For example, did having the support of your family,
the transplant staff or being educated about the evaluation process make it easier to
complete the medical evaluation process? Anything else?]
8. Now I’ll like you to list the 5 most important things (on the post it you’ve been provided)
which helped you complete the medical evaluation process. Place rankings beside the
motivators you’ve listed (with 1 being the most significant motivator, followed by 2 and
so on) [Probe: group members to list top 5 motivators and build a hierarchy]
TOPIC 5: BARRIERS TO COMPLETING THE MEDICAL EVALUATION
9. What are some things which made it difficult to complete the medical evaluation
process? [Probe: For example, perhaps insurance issues, the sheer number of tests, or
transportation difficulties, additional health problems, not having close friends or family
for support interfered with your ability to complete the evaluation? Anything else?]]
10. Now I’ll like you to list the 5 most important barriers (on the post it you’ve been
provided) which made it difficult to complete the medical evaluation process. Place
rankings beside the barriers you’ve listed (with 1 being the most significant barrier,
followed by 2 and so on) [Probe: group members to list top 5 barriers and build a
hierarchy]
IV. CLOSING:
Option 1: Time Still Remaining: Before we end the session, are there any other comments that
you have or topics that we missed in our discussion? Thank you for your time and participation.
Option 2: Time is Up: If, after today’s session, you think of any other comments or topics that
were missed please feel free to contact me (e.g., focus group facilitator) by email. Thank you for
your time and participation.
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Appendix D

ESRD Patients Nominal Focus group (Status 7) Protocol
I. Introduction
Thank you all for coming today/tonight. My name is Camilla Nonterah and I am a counseling
psychology doctoral student at VCU. Assisting me today is __________, Thank you for agreeing
to participate in this study. The information you provide will be very useful in helping us
understand the factors which impact the completion of the medical evaluation process for end
stage renal disease (ESRD) patients.
II. Description of Focus Group:
To begin, I would like to give you an overview of how this focus group will work. As you know,
the focus group will last for about 45 minutes to 1 hour. During this time period, I will ask you
some questions about your experience as a patient with end stage renal disease (ESRD). While I
encourage you to draw on your experience, we do not need to know the details of your medical
history or specific visits. The goal is for you to discuss the questions as a group. The most
important information will come from the range of everyone’s thoughts and ideas. It is very
important that everyone speaks their mind and participates, particularly if you have a different
perspective from others in the group. There are no “right” or “wrong” answers to the questions.
We are interested in the full range of perspectives.
My role is to help facilitate the discussion of this topic. I may ask specific individuals about their
thoughts or ideas if they have not had a chance to participate very much in the discussion. I also
may have to interrupt someone to ask that we get everyone’s opinion or to move on to another
topic. This is to ensure that we get everyone’s views on all the questions in the relatively short
time we have together.
Another important ground rule for this meeting is that we will respect the privacy of all group
members and keep the content of our discussion confidential. We will call each other only by
first names, and your verbal and written comments will be kept strictly confidential. I will be
audiotaping the discussion, and you may see me taking notes. These steps are necessary for us to
accurately record what is said today/tonight, but we will not include any information that will
personally identify you in our notes or recordings. At any point in time, you are free to stop
participating in the discussion or even leave. When we analyze our notes from this discussion,
we will be most interested in what the group as a whole has to say. After we complete the
analysis, we will erase and throw away the tape recording. When we publish the results of our
study, no individuals will be identified. Finally, please remember that located on your consent
form are the names and numbers of people you can call in future if you have questions about
your rights as a research participant.
Does anyone have any questions? [Answer any questions]
III. Warm up [7 minutes]
Before moving on to the main topic of our discussion, I would like to take a few moments for
everyone to introduce himself/herself. Specifically, I would like everyone to tell us their first
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name (you can also choose a pseudonym) and briefly tell us what their hobbies or interests are.
Let me begin….
[Moderator: Introduces herself/himself and then goes around the table.]
[Moderators Assistant: Will take notes on where particular people are sitting by creating a
diagram similar to the room and focus group layout. Individual first names will then be
associated with a numbered position in the diagram. These numbers make it possible to follow
more accurately who in the group is speaking when listening to the tapes again as well as
confidentially matching forms completed during the focus group with names.]
______________________________________________________________________________
TOPIC 1: INTRODUCTION
1. What made you interested in participating in this study? [Probe: Are you interested in the
topic? Are you looking for answers? Are you hoping that your participation will help
others?]
TOPIC 2: ESRD EXPERIENCE
2. Describe your experience so far as a patient with kidney disease? [Probe: What
challenges have you faced as a patient with ESRD?]
TOPIC 3: MEDICAL EVALUATION EXPERIENCE
3. What information have you been given about the medical evaluation process? [Probe::
Were you provided with information about the evaluation process itself and the number
of tests you would have to take for instance? Were you given with information about the
risks and benefits of kidney transplantation? Were you given information about what will
happen after transplantation?]
4. What information would have been helpful? [Probe: Would you have liked additional
information about the evaluation process such as the number of tests you have to take,
possible insurance issues, the importance of having others who could support you
through the process?]
5. Have you started the medical evaluation process? [Probe: When did you start the
process? What do you have left to finish?]
6. What tests have you done so far and what are you left to complete? [Probe: That is have
you finished the basic blood work and initial testing? What tests are you yet to
complete?]
7. What has it been like for you going through the medical evaluation process? [Probe:
Overall, would you say that your experience with has been generally positive or
negative? Why? Are there certain things which have been particularly difficult?]
TOPIC 4: BARRIERS TO COMPLETING THE MEDICAL EVALUATION
8. What things make it difficult to complete the medical evaluation process? [Probe: For
example, perhaps insurance issues, the sheer number of tests, or transportation
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difficulties, additional health problems, not having close friends or family for support
interfered with your ability to complete the evaluation? Anything else?]]
9. Now I’ll like you to list the 5 most important barriers (on the post it you’ve been
provided) which made/ have made it difficult to complete the medical evaluation process.
Place rankings beside the barriers you’ve listed (with 1 being the most significant barrier,
followed by 2 and so on) [Probe: group members to list top 5 barriers and build a
hierarchy]

TOPIC 5: MOTIVATORS TO COMPLETING THE MEDICAL EVALUATION
10. What do you think will help you complete the medical evaluation process for kidney
transplantation? [Probe: For example, will mobile testing, patient navigators, knowledge
about kidney transplantation, more education about the medical evaluation help you
complete the evaluation process?]
11. Let’s rank order the most important things which will help you complete the medical
evaluation process (with 1 being the most significant, followed by 2 and so on) explain
why you chose these rankings [Probe: for group discussion where group members list
top 5 barriers, build a hierarchy]
IV. CLOSING:
Option 1: Time Still Remaining: Before we end the session, are there any other comments that
you have or topics that we missed in our discussion? Thank you for your time and participation.
Option 2: Time is Up: If, after today’s session, you think of any other comments or topics that
were missed please feel free to contact me (e.g., focus group facilitator) by email. Thank you for
your time and participation.

115

Appendix E
NOMINAL FOCUS GROUP SURVEY
1. What is your race?
1
□
2
□
3
□
4
□
5
□
6
□
9
□

African American
Asian/Pacific Islander
Caucasian
American Indian/Alaskan
Mixed race (Specify:__________________________)
Other (Specify:______________________________)
NR/NA

2. Respondent’s gender:
1
□
Male
2
□
Female
3. What is your age? _______________(years)

4. What is the highest grade or degree you have completed? _____________ (Grade/Degree)
1
□
High school or less
2
□
Associate’s degree
3
□
Some college, no degree
4
□
More than Associate’s degree, but no Bachelor’s degree
5
□
Bachelor’s degree
6
□
Some graduate school, no degree
7
□
Master’s degree
8
□
Uncompleted graduate training beyond a Master’s degree
9
□
Doctorate
88
□
NR/NA
5. What is your marital status?
1
□
Single/never married
2
□
Married/cohabit
3
□
Divorced
4
□
Separated
5
□
Widowed
8
□
NR/NA
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6. What is your religion?
1
□
Atheist
2
□
Protestant
3
□
Catholic
4
□
Jewish
5
□
Mormon
6
□
Muslim
7
□
Greek/Russian Orthodox
8
□
Other (SPECIFY: _______________________________)
88
□
NR/NA
7. What is your annual household income?
1
□
$0 – 19,999 (<$20,000)
2
□
$20,000 – 39,999 (<$40,000)
3
□
$40,000 – 59,999 (<$60,000)
4
□
$60,000 – 79,999 (<$80,000)
5
□
$80,000 – 99,999 (<$100,000)
6
□
$100,000 +
99
□
DON’T KNOW
88
□
NR/NA
8. Have you completed the medical evaluation to be waitlisted for a kidney?
1
□
Yes
2
□
No
8a. If yes, how long did it take you to complete the process?
_______________(months/years)
8b. If no, how long have you been undergoing the medical evaluation process?
_______________(months/years)

9. Do you have health insurance?
1
□
Yes
2
□
No
10. How far are you from the transplant center? ______________ (Distance in miles)

11. Do you have the appropriate transportation to attend all your doctors’ appointments?
1
□
Yes
2
□
No
3
□
Other: Please explain __________________________
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Please tell me how much you think the following impact the medical evaluation process
12. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think your insurance status impact your ability to
complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

13. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think your income level (i.e. your annual income) impacts
your ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

14. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think the distance from the transplant center to the
patient’s house impacts your ability to complete the medical evaluation process?
1

2

3

4

5

6
7
Not at
all
Strongly impacts
15. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think comorbidities (i.e. a patient having other illness in
addition to ESRD) impacts your ability to complete the medical evaluation process?
1
2
3
4
5
6
7
Not at
all
Strongly impacts
16. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think your religious beliefs impact your ability to
complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

17. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, how much do you think your knowledge about different treatments impacts
your ability to complete the medical evaluation process?
1

2

3

4

5

Not at
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6
all

7
Strongly impacts

18. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly impacts” with 2, 3, 4,
5 and 6 in between, , how much do you think your knowledge about the medical evaluation
process impacts your ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

19. Health literacy is defined as the degree to which individuals have the ability to obtain,
process and understand basic health information and services in order to make appropriate
health decisions. On a scale from 1 to 7, with 1 being “Not at all” and 7 being “Strongly
impacts” with 2, 3, 4, 5 and 6 in between, how much do you think health literacy impacts your
ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

20. Medical mistrust is defined as concerns about trust and discrimination in populations of
patients with chronic illness. On a scale from 1 to 7, with 1 being “Not at all” and 7 being
“Strongly impacts” with 2, 3, 4, 5 and 6 in between, how much do you think medical mistrust
impacts your ability to complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Strongly impacts

21. Navigators are individuals who educate patients and help them navigate through the medical
system. On a scale from 1 to 7, with 1 being “No impact” and 7 being “Extremely positive
impact” with 2, 3, 4, 5 and 6 in between, how much would navigators impact your ability to
complete the medical evaluation process?
1

2

3

4

5

Not at

6
all

7
Extremely positive impact

22. Instrumental support networks are defined as the number of close friends or family that can
help with daily activities at home. On a scale from 1 to 7, with 1 being “No impact” and 7 being
“Extremely positive impact” with 2, 3, 4, 5 and 6 in between, how much would instrumental
support impact your ability to complete the medical evaluation process?
1

2

3

4

5

Not at
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6
all

7
Extremely positive impacts
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